IFRS Disclosure Checklist
IFRS Disclosure Checklist
IFRS Disclosure Checklist
Adopting IFRS A step-by-step illustration of the transition to IFRS Illustrates the steps involved in preparing the rst IFRS nancial statements. It takes into account the effect on IFRS 1 of the standards issued up to and including March 2004.
IAS 39 Achieving hedge accounting in practice Covers in detail the practical issues in achieving hedge accounting under IAS 39. It provides answers to frequently asked questions and step-by-step illustrations of how to apply common hedging strategies.
Financial instruments under IFRS High-level summary of the revised nancial instruments standards issued in December 2003, updated to reect IFRS 7 in September 2006. For existing IFRS preparers and rst-time adopters.
Illustrative condensed consolidated interim nancial information for existing preparers Illustrative information, prepared in accordance with IAS 34, for a ctional existing IFRS preparer. Includes a disclosure checklist and IAS 34 application guidance. Reects standards issued up to 31 May 2006.
Illustrative Consolidated Financial Statements Financial Reporting in Hyperinationary Economies Understanding IAS 29 2006 update (reecting impact of IFRIC 7) of a guide for entities applying IAS 29. Provides an overview of the standards concepts, descriptions of the procedures and an illustrative example of its application. Investment funds, 2006 Banking, 2006 Investment property, 2006 Corporate, 2007 Insurance, 2006 Realistic sets of nancial statements for existing IFRS preparers in the above sectors illustrating the required disclosure and presentation.
IFRS 3R: Impact on earnings the crucial Q&A for decision-makers Guide aimed at nance directors, nancial controllers and deal-makers, providing background to the standard, impact on the nancial statements and business, and summary differences with US GAAP.
Illustrative Interim Consolidated Financial Statements for First-time Adopters 2005 Realistic set of interim IFRS nancial statements for rst-time adopters. The nancial statements for the six months ended June 2005 illustrate the disclosure and presentation required by all IFRSs published up to and including December 2004.
IFRS Disclosure checklist 2007 Outlines the disclosures required by all IFRSs published up to September 2006.
Share-based Payment a practical guide to applying IFRS 2 Assesses the impact of the new standard, looking at the requirements and providing a step-by-step illustration of how to account for share-based payment transactions.
IFRS Measurement Checklist 2006 Outlines the measurement bases required by all IFRSs published up to September 2006.
SIC-12 and FIN 46R The Substance of Control Helps those working with special purpose entities to identify the differences between US GAAP and IFRS in this area, including examples of transactions and structures that may be impacted by the guidance.
IFRS for SMEs (proposals) Pocket Guide 2007 Provides a summary of the recognition and measurement requirements in the proposed IFRS for Small and Medium-Sized Entities published by the International Accounting Standards Board in February 2007.
Similarities and Differences a comparison of IFRS and US GAAP Presents the key similarities and differences between IFRS and US GAAP, focusing on the differences commonly found in practice. It takes into account all standards published up to August 2007.
IFRS Pocket Guide 2006 Provides a summary of the IFRS recognition and measurement requirements, including currencies, assets, liabilities, equity, income, expenses, business combinations and interim nancial statements.
Understanding nancial instruments A guide to IAS 32, IAS 39 and IFRS 7 Comprehensive guidance on all aspects of the requirements for nancial instruments accounting. Detailed explanations illustrated through worked examples and extracts from company reports.
* Earlier application is permitted (and disclosure of early application is required). Early adopters of these standards should be aware that there may be consequential amendments that affect the disclosure requirements of other standards.
Disclosure requirements resulting from standards and interpretations that have been issued but are not yet effective are included in Section A, except for disclosures relating to and IAS 1 Revised Presentation of Financial Statements, and IFRS 8, Operating Segments. These are outlined in Section H and I respectively for those entities that have early adopted these standards. Signicant updates that have been made to this publication since 2006 are highlighted in blue. The checklist does not deal with the measurement requirements of IFRS; a thorough reading of those standards and interpretations that are relevant to the reporting entitys circumstances will be necessary. This checklist is intended for general reference purposes only; it is not a substitute for reading the standards and interpretations themselves, or for professional judgement as to the fairness of presentation. Further specic information may be required in order to ensure fair presentation under IFRS depending on the circumstances. Additional accounting disclosures may be required in order to comply with local laws, national nancial reporting standards and/or stock exchange regulations.
PricewaterhouseCoopers
PricewaterhouseCoopers
Section A
A1
7
9 9 10 10 12 12 12 14 16 16 17 19 19 20 20 21 22 23 23 24 25 26 28 29 30 33 34 34 35 35 36 36 37 37 38 41 43 43 43 45 45 46 47 47 48 49 49 50
A2
A3
A4
A5
A6
A7
PricewaterhouseCoopers
A8
Disclosures relating to IFRS 7 1. General disclosures 2. Categories of nancial assets and nancial liabilities 3. Financial assets or nancial liabilities at fair value through prot or loss 4. Reclassication 5. Derecognition 6. Collateral 7. Allowance account for credit losses 8. Compound nancial instruments with multiple embedded derivatives 9. Defaults and breaches 10. Income statement and equity 11. Other disclosures 12. Nature and extent of risks arising from nancial instruments 13. Qualitative disclosures 14. Quantitative disclosures 15. Capital disclosures 16. Financial guarantees Non-current assets held for sale and discontinued operations
51 51 51 51 52 52 53 53 53 53 54 54 57 58 58 60 61 62
A9
Section B
B1 B2 B3 B4 B5 B6 B7 B8
65
67 67 68 68 69 69 69 72 72 72 73 73 73 73 74 74
Section C
C1 C2
Industry-specic disclosures
Construction contracts Agriculture 1. General disclosures 2. Additional disclosures where fair value of biological assets cannot be measured Public service concession arrangements Accounting by a lessor 1. Lessors nance leases 2. Lessors operating leases Arrangements that do not involve a lease in substance 3. Decommissioning, restoration and environmental rehabilitation funds
75
77 77 77 78 79 79 79 80 80 80
C3 C4
C5
PricewaterhouseCoopers
Section D
D1
83
85 85 85 87 87 88 91 97 101 107 109 111 112 112 114 117 119 119 120 123
Section I
Section J
PricewaterhouseCoopers
PricewaterhouseCoopers
PricewaterhouseCoopers
PricewaterhouseCoopers
Y-NA-NM
REF
A1 General disclosures
1. General disclosures
1p8 1. Include the following components in the nancial statements: (a) a balance sheet; (b) an income statement; (c) a statement of changes in equity showing either: (i) all changes in equity; or (ii) changes in equity other than those arising from transactions with equity holders acting in their capacity as equity holders; (d) a cash ow statement; and (e) notes, comprising a summary of signicant accounting policies and other explanatory notes. Financial statements should be clearly identied and distinguished from other information in the same published document (for example, by providing an index to the annual report). Clearly identify each component of the nancial statements. Include the following in the notes to the nancial statements: (a) the date when the nancial statements were authorised for issue; (b) the body who gave that authorisation; and (c) whether the entitys owners or others have the power to amend the nancial statements after issue. Display prominently the following information and repeat when necessary for a proper understanding of the information presented: (a) the name of the reporting entity or other means of identication, and any change in that information from the preceding balance sheet date; (b) whether the nancial statements cover the individual entity or a group of entities; (c) the balance sheet date or the period covered by the nancial statements, whichever is appropriate to the related component of the nancial statements; (d) the presentation currency; and (e) level of precision used in the presentation of gures in the nancial statements (for example, thousands or millions of units of the presentation currency). Disclose that the nancial statements comply with IFRS (as dened by IAS 1 para 11). Financial statements should not be described as complying with IFRS unless they comply with all the requirements of IFRS. An explicit and unreserved statement of compliance with IFRS should be made in the notes.
1p44
2.
1p46 10p17
3. 4.
1p46
5.
1p14
6.
PricewaterhouseCoopers
Section A1
Y-NA-NM
REF
21p54
2.
21p55
3.
21p56
4.
21p57
5.
3. Other disclosures
1p103 1. The notes to an entitys nancial statements should: (a) present information about: (i) the basis of preparation of the nancial statements; and (ii) the specic accounting policies selected and applied for signicant transactions and events; (b) disclose the information required by IFRS that is not presented elsewhere in the nancial statements; and (c) provide additional information that is not presented on the face of the nancial statements but is relevant to an understanding of any of them. Present the notes to the nancial statements in a systematic manner (refer also to IAS 1, para 105). Each item on the face of the balance sheet, income statement and cash ow statement should be cross-referenced to any related information in the notes.
1p104 1p104
2. 3.
10
PricewaterhouseCoopers
Y-NA-NM
REF
4. 1p36 1p36
1p38 1p39
Comparatives. (a) Disclose comparative information unless a standard or interpretation permits or requires otherwise; (b) Include comparative information in narrative and descriptive format when it is relevant to an understanding of the current periods nancial statements; (c) Disclose the nature, amount of, and reason for, any reclassication of comparative amounts; and (d) When it is impracticable to reclassify comparative amounts, disclose the reason for not reclassifying and the nature of the changes that would have been made if amounts were reclassied. If not disclosed elsewhere in the information published with the nancial statements, disclose: (a) the entitys domicile; (b) the entitys legal form; (c) the entitys country of incorporation; (d) the address of the entitys registered ofce (or principal place of business, if different from the registered ofce); (e) description of the nature of the entitys operations and its principal activities; (f) name of the immediate parent entity (or other controlling shareholder); (g) name of the ultimate parent entity; and (h) name of the ultimate controlling party. If neither the parent entity nor the ultimate parent entity present nancial statements available for public use, disclose the name of the next most senior parent that does so.
1p126
5.
DV1p9
6.
Companies may present outside the nancial statements a nancial review by management that describes and explains the main features of the entitys nancial performance and nancial position, and the principal uncertainties it faces. Refer to Section G. Companies with exploration and evaluation activities should disclose the amounts of assets, liabilities, income and expense and operating and investing cash ows arising from the exploration for and evaluation of mineral resources.
IFRS6p24(b) 7.
PricewaterhouseCoopers
11
Section A2
Y-NA-NM
REF
A2 Accounting policies
1. General disclosures
1p108 1. The accounting policies section should describe the following: (a) the measurement basis (or bases) used in the accounts (for example, historical cost, and historical cost modied by the revaluation of certain non-current assets); and (b) the other accounting policies used that are relevant to an understanding of the nancial statements. In consolidated nancial statements, the results of all subsidiaries, associates and joint ventures should be consolidated, equity accounted for or proportionally consolidated, as applicable, using uniform accounting policies for like transactions and other events in similar circumstances. In accordance with the transition provisions of each standard, disclose whether any standards have been adopted by the reporting entity before the effective date. Inappropriate accounting policies are not rectied either by disclosure of the accounting policies used or by notes or explanatory material.
2.
3.
1p16
4.
2. Specic policies
Disclosure of the following accounting policies is required: 1p110 1. Consolidation principles, including accounting for: (a) subsidiaries; and (b) associates. Business combinations. Joint ventures, including the method the venturer uses to recognise its interests in jointly controlled entities. Foreign currency transactions and translation. Property, plant and equipment for each class: (a) measurement basis (for example, cost less accumulated depreciation and impairment losses, or revaluation less subsequent depreciation); (b) depreciation method (for example, the straight-line method); (c) the useful lives or the depreciation rates used. Investment property. Disclose: (a) whether the entity applies the fair value model or the cost model; (b) if it applies the fair value model, whether, and in what circumstances, property interests held under operating leases are classied and accounted for as investment property; (c) when classication is difcult, the criteria the entity uses to distinguish investment property from owner-occupied property and from property held for sale in the ordinary course of business; (d) the methods and signicant assumptions applied in determining the fair value of investment property, including a statement on whether the determination of fair value was supported by market evidence or was more heavily based on other factors (which should be disclosed) because of the nature of the property and lack of comparable market data; and
2. 3. 4. 5.
40p75(a-e)
6.
12
PricewaterhouseCoopers
Y-NA-NM
REF
(e) the extent to which the fair value of investment property (as measured or disclosed in the nancial statements) is based on a valuation by an independent valuer who holds a recognised and relevant professional qualication and has recent experience in the location and category of the investment property being valued. 1p110 7. Other intangible assets. Disclose, for each class (distinguishing between internally generated and acquired assets): (a) accounting treatment (cost less amortisation, or, in very rare cases, revaluation less subsequent amortisation); (b) whether the useful lives are indenite or nite; (c) for intangible assets with nite useful lives, the amortisation period and amortisation methods used (for example, the straight-line method); (d) for intangible assets with indenite useful lives, that they have been tested for impairment annually and whenever there is an indication that the intangible asset may be impaired. Treatment of research costs and the basis for capitalisation of development costs and website development costs. Borrowing costs (for example, expensed or capitalised as part of a qualifying asset).
38p118(a) 38p118(a)(b)
38p108
8. 9.
10. For each class of nancial asset, nancial liability and equity instrument, disclose the accounting policies and methods adopted, including the criteria for recognition and the basis of measurement. As part of the disclosure of an entitys accounting policies, disclose, for each category of nancial assets, whether regular way purchases and sales of nancial assets are accounted for at trade date or at settlement date (refer to IAS 39, para 38). Provide disclosure of all signicant accounting policies, including the general principles adopted and the method of applying those principles to transactions, other events and conditions arising in the entitys business. In the case of nancial instruments, such disclosure includes: (a) the criteria applied in determining when to recognise a nancial asset or nancial liability, and when to derecognise it; (b) the measurement basis applied to nancial assets and nancial liabilities on initial recognition and subsequently; and (c) the basis on which income and expenses arising from nancial assets and nancial liabilities are recognised and measured. 11. Leases. 12. Inventories, including the cost formula used (for example, FIFO or weighted average cost). 13. Provisions. 14. Employee benet costs including policy for recognising actuarial gains and losses (refer to IAS 19 paras 92, 93 and 127). 15. Share-based payments. 16. Taxes, including deferred taxes. 17. Revenue recognition.
IFRS7pB5
IFRS7p21 1p108
PricewaterhouseCoopers
13
Section A2
Y-NA-NM
REF
18. The method adopted to determine the stage of completion of transactions involving the rendering of services. 19. Construction contracts, including: (a) methods used to determine contract revenue recognised; and (b) methods used to measure stage of completion of contracts in progress. 20. Government grants: (a) accounting policy; and (b) method of presentation in nancial statements.
20p39(a) 1p110
1p110, 7p46 21. Denition of cash and cash equivalents. 1p110 22. Segment reporting (required for listed companies): (a) denition of business and geographical segments; and (b) the basis for allocation of costs between segments.
IFRS6p24(b) 23. Exploration and evaluation expenditures including the recognition of exploration and evaluation assets. 36p80, 102 24. Policy for all assets including the selection of the cash-generating units to allocate the corporate assets and goodwill for the purpose of assessing such assets for impairment.
IFRS6p21, 23 25. Policy for allocating exploration and evaluation assets to cashgenerating units or groups of cash-generating units for the purpose of assessing such assets for impairment. 1p112 26. Any other signicant accounting policy that is not specically required by IFRS, but is selected and applied in accordance with IAS 8. An accounting policy may be signicant because of the nature of the entitys operations even if amounts for current and prior periods are not material. 27. The accounting policies section or other notes should describe managements judgements, apart from those involving estimations, made in the process of applying the entitys accounting policies that have the most signicant effect on the amounts recognised in the nancial statements.
1p113
8p28
2.
14
PricewaterhouseCoopers
Y-NA-NM
REF
(g) the amount of the adjustment relating to periods before those presented, to the extent practicable; and (h) if the retrospective application required is impracticable for a particular prior period, or for periods before those presented, the circumstances that led to the existence of that condition and a description of how and from when the change in accounting policy has been applied. These disclosures need not be repeated in the nancial statements of subsequent periods. 8p30 3. If an entity has not applied a new relevant standard or interpretation that has been issued but is not yet effective, disclose: (a) the fact that the entity did not apply the new standard or interpretation that has been issued but is not yet effective; and (b) known or reasonably estimable information relevant to assessing the possible impact that application of the new standard or interpretation will have on the entitys nancial statements in the period of initial application. In complying with the previous paragraph, an entity should consider disclosing: (a) the title of the new standard or interpretation; (b) the nature of the impending change or changes in accounting policy; (c) the date by which application of the standard or interpretation is required; (d) the date as at which it plans to apply the standard or interpretation initially; and (e) either: (i) a discussion of the impact that initial application of the standard or interpretation is expected to have on the entitys nancial statements; or (ii) if that impact is not known or reasonably estimable, a statement to that effect. On a voluntary change in accounting policy, disclose: (a) the nature of the change in accounting policy; (b) the reasons why applying the new accounting policy provides reliable and more relevant information; (c) the amount of the adjustment for the current period and each prior period presented, to the extent practicable: (i) for each nancial statement line item affected; and (ii) if IAS 33 applies to the entity, the impact on basic and diluted earnings per share; (d) the amount of the adjustment relating to periods before those presented, to the extent practicable; and (e) if the retrospective application required is impracticable for a particular prior period, or for periods before those presented, the circumstances that led to the existence of that condition and a description of how and from when the change in accounting policy has been applied. These disclosures need not be repeated in the nancial statements of subsequent periods.
DV8p31
4.
8p29
5.
PricewaterhouseCoopers
15
Sections A2-A3
Y-NA-NM
REF
IFRS6p13, 14
Exploration and evaluation expenditures: an entity may change its accounting policies for exploration and evaluation if the change makes the nancial statements more relevant to the economic decision-making needs of users and no less reliable, or more reliable and no less relevant to those needs. The criteria in IAS 8 should be followed for the change in the accounting policy.
1p82
2.
1p83
Additional line items, headings and sub-totals should be presented on the face of the income statement when such presentation is relevant to an understanding of the entitys nancial performance. All items of income and expense recognised in a period should be included in prot or loss unless a standard or interpretation requires otherwise. Items of income and expense should not be offset unless required or permitted by a standard or an interpretation. 3. Disclose, either on the face of the income statement, in the statement of changes in equity or in the notes, the amount of dividends recognised as distributions to equity holders during the period, and the related amount per share. Disclose the nature and amount of a change in an accounting estimate that has an effect in the current period or that is expected to have an effect in future periods. If it is impracticable to estimate the amount, disclose this fact.
1p78
1p32 1p95
8p39, 40
4.
16
PricewaterhouseCoopers
Y-NA-NM
REF
34p26
5.
If an estimate of an amount reported in an interim period changes signicantly during the nal interim period of the nancial year but a separate nancial report is not published for that nal interim period, the nature and amount of that change in estimate should be disclosed in a note to the annual nancial statements for that nancial year. This is only applicable when the reporting entity publishes an interim nancial report prepared in accordance with IAS 34.
2. Individual items
1p29, 86 1p87 1. When a class of similar items of income and expense are material, their nature and amount should be disclosed separately. Refer to examples shown in IAS 1 para 87, including write-downs of assets and reversals of such write-downs, restructuring costs and disposals of property, plant and equipment. Disclose the amount of each signicant category of revenue recognised during the period, including revenue arising from: (a) the sale of goods; (b) the rendering of services; (c) interest; (d) royalties; and (e) dividends. Disclose the amount of non-cash revenue arising from exchanges of goods or services included in each signicant category of revenue. Disclose the accounting treatment applied to any fee received in an arrangement that has the legal form of a lease but that in substance does not involve a lease under IAS 17, the amount recognised as income in the period, and the line item of the income statement in which it is included (refer to Section A5.18(c)). Either on the face of the income statement (encouraged by IAS 1 para 89) or in the notes to the income statement, analyse the items below revenue using a classication based on either the nature of expense or their function within the entity (whichever is reliable and more relevant). Refer to paras 6, 7 and 8 below, and the Appendix to IAS 1. If analysed by nature of expenses, this may comprises: (a) other income; (b) changes in inventories of nished goods and work in progress; (c) raw materials and consumables used; (d) employee benet costs; (e) depreciation and amortisation expense; and (f) other expenses. If analysed by function of expenses, this may comprises: (a) cost of sales; (b) gross prot; (c) other income; (d) distribution costs; (e) administrative expenses; and (f) other expenses. Entities classifying expenses by function should disclose additional information on the nature of expenses.
18p35(b)
2.
18p35(c)
3.
SIC27p10(b) 4.
1p88
5.
1p91
6.
1p92
7.
1p93
8.
PricewaterhouseCoopers
17
Section A3
Y-NA-NM
REF
9.
Such information should include: (a) depreciation and amortisation expense; and (b) employee benets costs.
10. Employee benets disclose: (a) the expense for dened contribution plans; (b) for dened benet plans the total expense for each of the following, and the line item(s) of the income statement in which they are included: (i) current service cost; (ii) interest cost; (iii) expected return on plan assets; (iv) expected return on any reimbursement right recognised as an asset; (v) actuarial gains and losses; (vi) past service cost; and (vii) the effect of any curtailment or settlement; 19p120A(m) (c) for dened benet plans: (i) the actual return on plan assets; and (ii) the actual return on any reimbursement right recognised as an asset; 19p131 (d) the expense resulting from other long-term employee benets, if signicant; and 19p142 (e) the expense resulting from termination benets, if signicant. 19p46 19p120A(g) 38p126 21p52(a) 11. Disclose research and development expenditure recognised as an expense during the period. 12. Disclose the amount of foreign exchange differences recognised in prot or loss except for those arising on nancial instruments measured at fair value through prot or loss in accordance with IAS 39.
36p126(a)(b) 13. Disclose for each class of assets the following amounts recognised during the period, and the line item(s) of the income statement in which they are included: (a) impairment losses; and (b) reversals of impairment losses. 14. Disclose the following amounts recognised during the period and the line item(s) of the income statement in which they are included: 38p118(d) (a) amortisation of intangible assets (by each class); and IFRS3p67(g) (b) excess of acquirers interest in the net fair value of acquirees assets, liabilities and contingent liabilities over cost recognised as income. 40p75(f) 15. Investment property disclose: (a) rental income; (b) direct operating expenses including repairs and maintenance arising from investment property that generated rental income during the period; (c) direct operating expenses including repairs and maintenance arising from investment property that did not generate rental income during the period; and (d) the cumulative change in fair value recognised in prot or loss on a sale of investment property from a pool of assets in which the cost model is used into a pool in which the fair value model is used;
40p32C
18
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS7p20
16. Disclose the following material items resulting from nancial assets and nancial liabilities: (a) income; (b) expense; (c) gains; and (d) losses. 17. The disclosures in para 16 above should include the following: (a) net gains or losses on: (i) nancial assets or nancial liabilities at fair value through prot or loss, showing separately those on nancial assets or nancial liabilities designated as such upon initial recognition, and those on nancial assets or liabilities that are classied as held for trading in accordance with IAS 39; (ii) available-for-sale nancial assets, showing separately the amount of gain or loss recognised directly in equity during the period, and the amount removed from equity and recognised in prot or loss for the period; (iii) held-to-maturity investments; (iv) loans and receivables; and (v) nancial liabilities measured at amortised cost; (b) total interest income and total interest expense (calculated using the effective interest method) for nancial assets or liabilities that are not at fair value through prot or loss; (c) fee income and expense (other than amounts included in determining the effective interest rate) arising from: (i) nancial assets and liabilities that are not at fair value through prot or loss; and (ii) trust and other duciary activities that result in the holding or investing of assets on behalf of individuals, trusts, retirement benet plans and other institutions; (d) interest income on impaired nancial assets; and (e) the amount of any impairment loss for each class of nancial asset.
IFRS7p20
3. Income tax
12p79 12p81(c) 1. 2. Disclose the major components of tax expense (income). IAS 12 para 80 gives examples of the major components of tax expense (income). Provide an explanation of the relationship between tax expense (income) and accounting prot in either of the following forms: (a) numerical reconciliation between tax expense (income) and product of accounting prot, multiplied by the applicable tax rate(s), disclosing also the basis on which the applicable tax rate(s) is (are) computed (refer to IAS 12 para 85); or (b) a numerical reconciliation between the average effective tax rate and the applicable tax rate, disclosing also the basis on which the applicable tax rate is computed (refer to IAS 12 para 85). Provide an explanation of changes in the applicable tax rate(s) compared to the previous period.
12p81(d)
3.
4. Extraordinary items
1p85 1. Items of income and expense should not be presented as extraordinary items anywhere, either on the face of the income statement nor in the notes.
PricewaterhouseCoopers
19
Section A4
Y-NA-NM
REF
1p96(c)
1p96(d)
20
PricewaterhouseCoopers
Y-NA-NM
REF
current or deferred tax on items taken directly to or transferred from equity; equity-settled share-based payment transactions; and (v) retained earnings; and (i) the equity conversion element of convertible debt. The change in the revaluation surplus arising from a change in the existing decommissioning, restoration and similar liabilities should be separately identied and disclosed.
1p96(c)
1p96(d)
32p34 16p77(f) 38p124(b) IFRS7p20 IFRS7p23 21p52(b) 12p81(a) IFRS2p50 1p97(b) 32p28
PricewaterhouseCoopers
21
Section A4
Y-NA-NM
REF
3. General disclosures
These disclosures apply irrespective of whether the entity presented a statement of changes in equity or a statement of recognised income or expense. 1p76(b) 16p77(f) 38p124(b) 1. A description of the nature and purpose of each reserve within shareholders equity, including restrictions on the distribution of the revaluation reserves (this usually includes details of any restrictions on distributions for each reserve in shareholders equity, although it is not specied in IAS 1). The aggregate current and deferred tax relating to items charged or credited to equity. It is useful to disclose the analysis by category of temporary differences. The amount of impairment losses and the amount of reversals of impairment losses, recognised directly in equity during the period, for each class of assets. Disclose the following for each class of share capital either on the face of the balance sheet or in the notes (this information is usually disclosed in the notes): (a) the number of shares authorised; (b) the number of shares issued and fully paid, and issued but not fully paid; (c) par value per share, or that the shares have no par value; (d) a reconciliation of the number of shares outstanding at the beginning and end of the year; (e) the rights, preferences and restrictions attached to each class of share capital, including restrictions on the distribution of dividends and the repayment of capital; (f) shares in the entity held by the entity itself or by the entitys subsidiaries or associates; and (g) shares reserved for issuance under options and sales contracts, including the terms and amounts. Certain types of preference shares must be classied as liabilities (not in equity). Refer to IAS 32 para 18(a). When a change in the redemption prohibition leads to a transfer between nancial liabilities and equity, the entity should disclose separately the amount, timing and reason for the transfer. An entity without share capital, such as a partnership, should disclose information equivalent to that required in para 4 above, showing movements during the period in each category of equity interest and the rights, preferences and restrictions attached to each category of equity interest. Disclose the amount of dividends proposed or declared before the nancial statements were authorised for issue but not recognised as a distribution to equity holders during the period, and the related amount per share. Disclose the amount of any cumulative preference dividends not recognised.
12p81(a)
2.
3.
4.
1p77
7.
10p12 1p125(a)
8.
1p125(b) IFRS5p38
9.
10. Any cumulative income or expense recognised directly in equity in relation to a non-current asset (or disposal group) classied as held for sale.
PricewaterhouseCoopers
Y-NA-NM
REF
1p69
Additional line items, headings and subtotals should be presented on the face of the balance sheet when such presentation is relevant to an understanding of the entitys nancial position. Refer to Section A9 for disclosures relating to discontinued operations.
IAS 1 does not prescribe the order or format for presenting balance sheet items. Assets and liabilities should not be offset unless required or permitted by a standard or interpretation. 2. Disclose further sub-classications of the line items presented, classied in a manner appropriate to the entitys operations, either on the face of the balance sheet or in the notes to the balance sheet. Refer to IAS 1 para 75 for examples. Is the current/non-current distinction of assets and liabilities made on the face of the balance sheet? (a) Yes ensure that classication rules in IAS 1 paras 57-67 are applied; (b) No in this exception, ensure that a presentation based on liquidity provides information that is reliable and more relevant. Ensure also that assets and liabilities are presented broadly in order of their liquidity. Whichever method of presentation in para 3 above is applied, disclose the non-current portion (the amount expected to be recovered or settled after more than 12 months) for each asset and liability item that combines current and non-current amounts.
1p51
3.
1p52
4.
PricewaterhouseCoopers
23
Section A5
Y-NA-NM
REF
2. Measurement uncertainty
1p116 1. The notes should include information about the key assumptions concerning the future, and other key sources of estimation uncertainty at the balance sheet date, that have a signicant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next nancial year. The notes should include details of: (a) the nature of these assets and liabilities; and (b) their carrying amount as at the balance sheet date. For each class of provision, provide: (a) a brief description of the nature of the obligation and of the expected timing of any resulting outows of economic benets; (b) an indication of the uncertainties about the amount or timing of those outows (where necessary to provide adequate information, disclose the major assumptions made concerning future events, as addressed in IAS 37 para 48); and (c) the amount of any expected reimbursement, stating the amount of any asset that has been recognised for that expected reimbursement. If an estimate of an amount reported in an interim period for example, a provision is changed signicantly during the nal interim period of the nancial year but a separate nancial report is not published for that nal interim period, the nature and amount of that change in estimate should be disclosed in a note to the annual nancial statements for that nancial year.
37p85
2.
34p26
3.
This item is applicable only when the reporting entity publishes an interim nancial report prepared in accordance with IAS 34. 4. Note that certain standards require further specic disclosures about sources of estimation uncertainty and judgements. The specic disclosure requirements in the other sections of this disclosure checklist include: (a) Methods and assumptions applied in determining fair values for: (i) investment property (Section A2.2, para 6); (ii) property, plant and equipment (Section A5.3, para 3(c) and 3(d)); (iii) intangible assets (Section A5.5, para 5); (iv) impairment of assets basis and key assumptions for determining impairment losses or reversals (Section A5.7, paras 1 and 4); (v) business combinations basis for determining impairment losses or reversals (Section A7.1 para 1(e)) and adjustments made to provisional values (Section A7.1 para 6); (vi) nancial instruments (Section A8); (vii) share-based payments (Section B7, paras 2 to 5); and (viii) agricultural produce and biological assets (Section C2.1 para 4). (b) Nature, timing and certainty of cash ows relating to the following: (i) contingencies (Section A5.23); (ii) nancial instruments terms and conditions that may affect the amount, timing and certainty of future cash ows;
37p86 IFRS7p31
24
PricewaterhouseCoopers
Y-NA-NM
REF
SIC 29p6-7
IFRS4p37
19p120A(u) IFRS4p37
26p35
(iii) public service concession arrangements terms and conditions that may affect the amount, timing and certainty of future cash ows (Section C3); and (iv) insurance information about nature, timing and uncertainty of future cash ows from insurance contracts (Section E, para 2). (c) Other relevant disclosures: (i) impairment of assets key assumptions for cash ow projections, periods covered by projections, growth rates for extrapolations and discount rates in determining value in use (Section A5.7, paras 1 and 4); (ii) post-employment dened benet plans principal actuarial assumptions (Section A5.17, paras 14 and 15). (iii) insurance process used to determine assumptions that have the greatest effect on the measurement of recognised assets, liabilities, income and exposes from insurance contracts. When practicable, an insurer should also give quantied disclosure of those assumptions; and (iv) retirement benet plan entities actuarial assumptions (Section F).
16p73(d)
16p73(e)
2.
1p36
PricewaterhouseCoopers
25
Section A5
Y-NA-NM
REF
16p77
3.
For PPE stated at revalued amounts, disclose: (a) the effective date of the revaluation; (b) whether an independent valuer was involved; (c) the methods and signicant assumptions applied in estimating the items fair values; (d) the extent to which the items fair values were determined directly by reference to observable prices in an active market or recent market transactions on arms length terms, or the extent to which they were estimated using other valuation techniques; and (e) for each revalued class of PPE, the carrying amount that would have been recognised had the assets been carried under the cost model. Refer also to the disclosures on revaluation surplus in Section A4.
4. 5. 6. 7.
Disclose the existence and amounts of PPE whose title is restricted. Disclose the amounts of PPE pledged as security for liabilities. Disclose the amount of expenditures on account of PPE in the course of construction. If it is not disclosed separately on the face of the income statement, disclose the amount of compensation from third parties for items of PPE that were impaired, lost or given up and that is included in prot or loss. Borrowing costs. Disclose: (a) the amount of borrowing costs capitalised during the period; and (b) the capitalisation rate used to determine the amount of borrowing costs eligible for capitalisation. Provide the net carrying amount for each class of assets held under nance leases.
10. Voluntary disclosures: (a) the carrying amount of temporarily idle PPE; (b) the gross carrying amount of any fully depreciated PPE that is still in use; (c) the carrying amount of PPE retired from active use and not classied as held for sale under IFRS 5; and (d) when PPE is carried at cost less depreciation, the fair value of PPE if this is materially different from the carrying amount. 11. Exploration and evaluation assets. An entity should treat these assets as a separate class of assets and make the disclosure required by IAS 16 if they are classied as items of property, plant and equipment.
IFRS6p25
4. Investment property
The disclosures below apply in addition to those in IAS 17. In accordance with IAS 17, the owner of an investment property provides lessors disclosures about leases into which it has entered. An entity that holds an investment property under a nance or operating lease provides lessees disclosures for nance leases and lessors disclosures for any operating leases into which it has entered.
26
PricewaterhouseCoopers
Y-NA-NM
REF
40p76, 79(d) 1.
Provide a reconciliation of the carrying amount of investment property at the beginning and end of each period presented, showing separately those carried at fair value and those measured at cost because the fair value cannot be determined reliably: (a) additions; disclosing separately those additions resulting from acquisitions and those resulting from subsequent expenditure recognised in the carrying amount of the asset; (b) additions resulting from acquisitions through business combinations; (c) assets classied as held for sale or included in a disposal group classied as held for sale in accordance with IFRS 5 and other disposals; (d) the net gains or losses from fair value adjustments (where the fair value model in IAS 40 is used); (e) net exchange differences arising on the translation of the nancial statements into a different presentation currency and on translation of a foreign operation into the presentation currency of the reporting entity; (f) transfers to and from inventories; and owner-occupied property; and (g) other changes. If there has been no valuation by an independent professionally qualied valuer, disclose the fact. If the fair value model is used, but certain investment properties are carried under the IAS 16 cost model because of the lack of a reliable fair value, provide: (a) a description of the investment property; (b) an explanation of why fair value cannot be reliably measured; (c) the range of estimates within which fair value is highly likely to lie; and (d) if the entity disposes of investment property whose fair value previously could not be measured reliably, disclose: (i) that the entity has disposed of the investment property not carried at fair value; (ii) the carrying amount of that investment property at the time of sale; and (iii) the gain or loss on disposal. Disclose the existence and amounts of restrictions on the realisability of investment property or the remittance of income and proceeds of disposal. If an entity uses the cost model, disclose in addition to para 1 above: (a) depreciation methods used; (b) the useful lives or the depreciation rates used; and (c) the gross carrying amount and the accumulated depreciation (aggregated with accumulated impairment losses): (i) at the beginning of the period; and (ii) at the end of the period; (d) a reconciliation of the carrying amount at the beginning and end of the period of: (i) depreciation; (ii) the amount of impairment losses recognised, and the amount of impairment losses reversed, during the period in accordance with IAS 36;
40p75(e) 40p78
2. 3.
40p75(g)
4.
40p79(d)
PricewaterhouseCoopers
27
Section A5
Y-NA-NM
REF
40p79(e)
(iii) the net exchange differences arising on the translation of the nancial statements into a different presentation currency, and on translation of a foreign operation into the presentation currency of the reporting entity; and (e) the fair value of investment property. When an entity cannot reliably determine the fair value of the investment property, disclose: (i) a description of the investment property; (ii) an explanation of why fair value cannot be reliably measured; and (iii) the range of estimates within which fair value is highly likely to lie. 6. When a valuation obtained for investment property is adjusted signicantly for the purpose of the nancial statements (for example, to avoid double-counting of assets or liabilities that are recognised as separate assets and liabilities as described in IAS 40 para 50), disclose: (a) a reconciliation between the valuation obtained and the adjusted valuation included in the nancial statements; and (b) separately, in the reconciliation: (i) the aggregate amount of any recognised lease obligations that have been added back; and (ii) any other signicant adjustments.
40p77
38p118 38p118(e)
38p118(c)
28
PricewaterhouseCoopers
Y-NA-NM
REF
1p36 38p122(a) 2.
IAS 38 para 119 gives examples of separate classes of intangible assets. Comparative information for these items is required. For intangible assets with indenite useful lives, disclose: (a) the carrying amount; and (b) the reasons supporting the assessment of an indenite useful life. Provide the following for any individual intangible asset that is material to the nancial statements of the entity as a whole: (a) a description of the asset; (b) its carrying amount; and (c) remaining amortisation period. For intangible assets carried at revalued amounts, disclose for each class of intangible assets: (a) the effective date of the revaluation; (b) the carrying amount of revalued intangible assets; and (c) the carrying amount that would have been included in the nancial statements had the cost model been used (as if the assets had been carried at cost less accumulated depreciation and accumulated impairment losses). Disclose the method and signicant assumptions applied in estimating the fair values of the intangible assets. Disclose: (a) the existence and amounts of intangible assets whose title is restricted; and (b) the amounts of intangible assets pledged as security for liabilities. For intangible assets acquired through a government grant and initially recognised at fair value (refer to IAS 38 para 44), disclose: (a) the fair value initially recognised for these assets; (b) their carrying amount; and (c) whether they are carried at cost less depreciation or at revalued amounts. Voluntary disclosures: (a) fully amortised intangible assets that are still in use; and (b) details of signicant intangible assets controlled by the entity but not recognised as assets because they did not meet the recognition criteria in IAS 38 or because they were acquired or generated before IAS 38 became effective. Exploration and evaluation assets an entity should treat these assets as a separate class of assets and make the disclosures required by IAS 38 if they are classied as intangible assets.
38p122(b)
3.
38p124(a)
4.
38p124(c) 38p122(d)
5. 6.
38p122(c)
7.
DV38p128
8.
IFRS6p25
9.
1 The IASB no longer uses the term negative goodwill. The ofcial term is excess of acquirers interest in the net fair value of acquirees identiable assets, liabilities and contingent liabilities over cost. The term negative goodwill is used in this publication in the interest of brevity.
PricewaterhouseCoopers
29
Section A5
Y-NA-NM
REF
disposals; impairment losses recognised during the period; net exchange differences arising during the period; other changes during the period; and gross carrying amount and accumulated impairment losses at the end of the period.
Comparative information for these items is required. If the information that is required to be disclosed by IFRS 3 does not disclose enough information to enable users to evaluate the nature and nancial effect of a business combination, disclose such additional information as is necessary to meet that objective.
7. Impairment of assets
17p32, 57 The disclosure requirements of IAS 36 apply to owned assets and to the amounts of leased assets held under nance leases in the lessees accounts. 1. Where an impairment loss, recognised or reversed for an individual asset or cash-generating unit (CGU) during the period, is material to the nancial statements of the reporting entity, the entity is required to disclose: (a) the events and circumstances that led to the recognition or reversal of the impairment loss; (b) the amount of the impairment loss recognised or reversed; (c) for an individual asset: (i) the nature of the asset; and (ii) the segment to which the asset belongs (based on primary format) (refer to Section D1); (d) for a CGU: (i) a description of the CGU (such as whether it is a product line, a plant, a business operation, a geographical area, or a reportable segment as dened in IAS 14) (refer to Section D1); (ii) the amount of the impairment loss recognised or reversed: by class of assets; and by reportable segment based on the entitys primary format (refer to Section D1); and (iii) if the aggregation of assets for identifying the CGU has changed since the previous estimate of the CGUs recoverable amount, the entity should describe the current and former method of aggregating assets and the reasons for changing the way the CGU is identied; (e) whether the recoverable amount of the asset or CGU is its fair value less costs to sell or its value in use; (f) the basis used to determine fair value less costs to sell if the recoverable amount is the fair value less costs to sell (for example, whether it was determined by reference to an active market or in some other way); and (g) if the recoverable amount is value in use, the discount rates used in current estimate and previous estimate (if any) of value in use. The disclosures in this section relating to segments are applicable to entities that apply IAS 14 refer to Section D1.
36p130
PricewaterhouseCoopers
Y-NA-NM
REF
36p131
2.
Disclose the following information for the aggregate impairment losses and the aggregate reversals of impairment losses recognised during the period for impairment losses or reversals that are not individually material: (a) the main classes of assets affected by impairment losses (or reversals of impairment losses); and (b) the main events and circumstances that led to the recognition (reversal) of these impairment losses. If any portion of the goodwill acquired in a business combination during the reporting period has not been allocated to a CGU at the reporting date the entity should: (a) disclose the amount of the unallocated goodwill; and (b) disclose the reasons why that amount remains unallocated. Where the carrying amount of goodwill or intangible assets with indenite useful lives allocated to a CGU (or group of CGUs) is signicant in comparison to the total carrying amount of goodwill or intangible assets with indenite useful lives, the entity should disclose the following for each CGU (or group of CGUs): (a) the carrying amount of allocated goodwill; (b) the carrying amount of intangible assets with indenite useful lives; (c) the basis on which the recoverable amounts of the CGUs (group of CGUs) have been determined (value in use or fair value less cost to sell); (d) if the recoverable amounts of the CGUs are based on value in use: (i) a description of each key assumption on which management has based its cash ow projections for the period covered by the most recent budgets/forecasts (key assumptions are those to which the recoverable amounts of the CGUs are most sensitive); (ii) a description of managements approach to determining the values assigned to each key assumption, whether those values reect past experience and/or are consistent with external sources of information, if appropriate. If not, disclose how and why they differ from past experience and/or external sources of information; (iii) the period over which management has projected cash ows based on nancial budgets/forecasts approved by management and, when a period greater than ve years is used for a CGU (or group of CGUs), an explanation of why that longer period is justied; (iv) the growth rate used to extrapolate cash ow projections beyond the period covered by the most recent budgets/forecasts, and the justication for using any growth rate that exceeds the long-term average growth rate for the products, industries, or country or countries in which the entity operates, or for the market to which the CGU is dedicated; and (v) the discount rate(s) applied to the cash ow projections;
36p133
3.
36p134
4.
PricewaterhouseCoopers
31
Section A5
Y-NA-NM
REF
(e) if the CGUs recoverable amounts are based on the fair value less cost to sell, disclose the methodology used to determine the fair value less cost to sell. If fair value less cost to sell is not determined using observable market prices for the CGUs, the following information should also be disclosed: (i) a description of each key assumption on which management has based its determination of fair value less cost to sell (key assumptions are those to which the recoverable amounts of the CGUs are most sensitive); and (ii) a description of managements approach to determining the values assigned to each key assumption, whether those values reect past experience and/or, if appropriate, are consistent with external sources of information, and if not, how and why they differ from past experience and/or external sources of information; and (f) if a reasonably possible change in a key assumption on which management has based its determination of the CGUs recoverable amount would cause the CGUs carrying amount to exceed its recoverable amount: (i) the amount by which the aggregate of the CGUs recoverable amounts exceeds the aggregate of their carrying amounts; (ii) the value assigned to the key assumptions; and (iii) the amount by which the value assigned to the key assumption must change, after incorporating any consequential effects of that change on the other variables used to measure recoverable amount, in order for the CGUs recoverable amount to be equal to its carrying amount. 36p135 5. If some or all of the carrying amount of goodwill or intangible assets with indenite lives is allocated across multiple CGUs (or groups of CGUs) and the amount allocated to each CGU (or group of CGUs) is not individually signicant, that fact should be disclosed, together with the aggregate carrying amount of goodwill or intangible assets with indenite lives allocated to those CGUs (or group of CGUs). If the recoverable amounts of any of those CGUs (or group of CGUs) are based on the same key assumptions, and the aggregate carrying amounts of goodwill or intangible assets with indenite lives allocated to them is signicant, an entity should disclose that fact, together with: (a) the aggregate carrying amount of goodwill allocated to those CGUs (or groups of CGUs); (b) the aggregate carrying amount of intangible assets with indenite useful lives allocated to those CGUs (or group of CGUs); (c) a description of the key assumption(s); (d) a description of managements approach to determining the values assigned to each key assumption, whether those values reect past experience and/or, if appropriate, whether they are consistent with external sources of information. If not, disclose how and why they differ from past experience and/or external sources of information; and (e) if a reasonably possible change in the key assumptions would cause the CGUs (or group of CGUs) carrying amount to exceed its recoverable amount: (i) the amount by which the aggregate of the recoverable amounts of the CGUs exceeds the aggregate of their carrying amounts;
36p135
6.
PricewaterhouseCoopers
Y-NA-NM
REF
(ii) the value assigned to the key assumptions; and (iii) the amount by which the value assigned to the key assumption must change, after incorporating any effects of that change in the other variables used to measure the recoverable amount, in order for the CGUs (or group of CGUs) recoverable amount to be equal to their carrying amount. 36p136 7. If the most recent detailed calculation of the recoverable amount of a CGU made in a preceding period is carried forward and used in the impairment test for that unit in the current period, the disclosures required in paras 5 and 6 above relate to the carried forward calculation of recoverable amount.
8. Associates
28p38 1. Associates accounted for using the equity method. Disclose: (a) associates as a separate item under non-current assets; (b) the investors share of the prot or loss of associates; and (c) separately, the investors share of any discontinued operations of associates. The following disclosures should be made: (a) the fair value of investments in associates (individually) for which there are published price quotations; (b) summarised nancial information of associates (individually for each signicant associate), including the aggregated amounts of assets, liabilities, revenues and prot or loss; (c) the reasons why the presumption that an investor does not have signicant inuence is overcome if the investor holds, directly or indirectly through subsidiaries, less than 20% of the voting or potential voting power of the investee but concludes that it has signicant inuence; (d) the reasons why the presumption that an investor has signicant inuence is overcome if the investor holds, directly or indirectly through subsidiaries, 20% or more of the voting or potential voting power of the investee but concludes that it does not have signicant inuence; (e) the reporting date of an associates nancial statements, when it is different from that of the investor, and the reason for using a different reporting date; (f) the nature and extent of any signicant restrictions (for example, resulting from borrowing arrangements or regulatory requirements) on associates ability to transfer funds to the investor in the form of cash dividends, or repayment of loans or advances; (g) the unrecognised share of an associates losses, both for the period and cumulatively, if an investor has discontinued recognition of its share of an associates losses; (h) the fact that an associate is not accounted for using the equity method, in accordance with IAS 28 para 13; and (i) summarised nancial information of associates, either individually or in groups, that are not accounted for using the equity method, including the amounts of total assets, total liabilities, revenues and prot or loss.
28p37
2.
PricewaterhouseCoopers
33
Section A5
Y-NA-NM
REF
28p39
3.
The investors share of changes recognised directly in the associates equity should be recognised directly in equity by the investor and should be disclosed in the statement of changes in equity, as required by IAS 1. In accordance with IAS 37, disclose: (a) the investors share of an associates contingent liabilities incurred jointly with other investors; and (b) those contingent liabilities that arise because the investor is liable for all or part of the liabilities of the associate.
28p40
4.
9. Joint ventures
31p56 1. A venturer should disclose: (a) a listing and description of interests in signicant joint ventures and the proportion of ownership interest held in jointly controlled entities; and (b) the aggregate amounts of each of current assets, long-term assets, current liabilities, long-term liabilities, income and expenses related to its interests in joint ventures. Disclose separately from other contingent liabilities: (a) any contingent liabilities that the venturer has incurred in relation to its interests in joint ventures and its share in each of the contingent liabilities that have been incurred jointly with other venturers; (b) its share of the contingent liabilities of the joint ventures themselves for which it is contingently liable; and (c) the contingent liabilities that arise because the venturer is contingently liable for the liabilities of the other venturers of a joint venture. Disclose separately from other commitments the aggregate of: (a) any capital commitments of the venturer in relation to its interests in joint ventures and its share in the capital commitments that have been incurred jointly with other venturers; and (b) its share of the capital commitments of the joint ventures themselves.
31p54
2.
31p55
3.
10. Subsidiaries
27p40 1. In consolidated nancial statements, disclose: (a) the nature of the relationship between the parent and a subsidiary when the parent does not own, directly or indirectly through subsidiaries, more than half of the voting power; (b) the reasons why the ownership, held directly or indirectly through subsidiaries, of more than half of the voting or potential voting power of an investee does not constitute control; (c) the reporting date of a subsidiarys nancial statements when it is different from that of the parent, and the reason for using a different reporting date or period; and (d) the nature and extent of any signicant restrictions (for example, resulting from borrowing arrangements or regulatory requirements) on the ability of subsidiaries to transfer funds to the parent in the form of cash dividends or to repay loans or advances.
34
PricewaterhouseCoopers
Y-NA-NM
REF
27p42
2.
When a parent (other than a parent covered by IAS 27 para 41 see Section B6.1), venturer with an interest in a jointly controlled entity or an investor in an associate prepares separate nancial statements, disclose: (a) the fact that the statements are separate nancial statements and the reasons why those statements are prepared if not required by law; (b) a list of signicant investments in subsidiaries, jointly controlled entities and associates, including: (i) the name; (ii) country of incorporation or residence; (iii) proportion of ownership interest; and (iv) if different, proportion of voting power held; and (c) a description of the method used to account for the investments listed under (b).
The entity should identify the consolidated nancial statements prepared in accordance with IAS 27 para 9, IAS 28 and IAS 31 to which the separate nancial statements relate.
2.
IFRS7p20 (a)(ii)
3.
IFRS7p12
4.
39p37(a)
12. Inventory
2p36(b) 1. 2p37,1p75(c) Disclose the carrying amount of inventories in total, sub-classied by main categories appropriate to the entity. For example: merchandise, production supplies, materials, work in progress, and nished goods. Disclose the carrying amount of inventories carried at fair value less costs to sell.
2p36(c)
2.
PricewaterhouseCoopers
35
Section A5
Y-NA-NM
REF
2p36(d)(e) 2p36(f)(g)
3. 4.
Disclose the amount of inventories and the amount of write-down recognised as expenses during the period. Disclose the amount of, and circumstances or events leading to, the reversal of any write-down that is recognised as a reduction in the amount of inventories recognised as expense in the period. Disclose the carrying amount of inventories pledged as security for liabilities. Where inventories combine current and non-current amounts, disclose the amount of the non-current portion that is expected to be recovered or settled after more than 12 months (refer to IAS 1 para 59).
2p36(h) 1p52
5. 6.
IFRS7p20(e) 2. 1p52 3.
1p52
4.
12p71 12p74
12p81(f)
36
PricewaterhouseCoopers
Y-NA-NM
REF
12p81(g)
6.
In respect of each type of temporary difference, and in respect of each type of unused tax losses and unused tax credits, disclose: (a) the amount of the deferred tax assets and liabilities recognised in the balance sheet for each period presented; and (b) the amount of the deferred tax income or expense recognised in the income statement, if this is not apparent from the changes in the amounts recognised in the balance sheet (for example, where there are deferred tax items charged or credited to equity during the period). It is a helpful proof to display the movements during the period in each category of temporary differences in the deferred tax account, although it is not required by IAS 12.
12p82
7.
Disclose the amount of a deferred tax asset and the nature of the evidence supporting its recognition, when: (a) the utilisation of the deferred tax asset is dependent on future taxable prots in excess of the prots arising from the reversal of existing taxable temporary differences; and (b) the entity has suffered a loss in either the current or preceding period in the tax jurisdiction to which the deferred tax asset relates. Disclose the aggregate current and deferred tax relating to items charged or credited to equity. For deferred taxes, it is useful to disclose the analysis by category of temporary differences. If income taxes are payable at a higher or lower rate if part or all of the net prot or retained earnings is paid out as a dividend, disclose: (a) the nature of the potential income tax consequences that would result from the payment of dividends; and (b) the amounts of the potential income tax consequences practically determinable, and whether there are any potential income tax consequences not practically determinable.
12p81(a)
8.
12p82A
9.
1p52
2.
16. Provisions
37p84 1. For each class of provision, disclose: (a) the carrying amount at the beginning of the period; (b) exchange differences from the translation of foreign entities nancial statements; (c) provisions acquired through business combinations;
PricewaterhouseCoopers
37
Section A5
Y-NA-NM
REF
(d) additional provisions made in the period and increases to existing provisions; (e) amounts used (incurred and charged against the provision); (f) amounts reversed unused; (g) the increase during the period in the discounted amount arising from the passage of time and the effect of any change in the discount rate; and (h) the carrying amount at the end of the period. Comparative information for these items is not required. 1p52 2. Where any provision combines current and non-current amounts, disclose the amount of the non-current portion that is expected to be recovered or settled after more than 12 months (refer also to IAS 1 para 61). For each class of provision, provide: (a) a brief description of the nature of the obligation and of the expected timing of any resulting outows of economic benets; (b) an indication of the uncertainties about the amount or timing of those outows (where necessary to provide adequate information, disclose the major assumptions made concerning future events, as addressed in IAS 37 para 48); and (c) the amount of any expected reimbursement, stating the amount of any asset that has been recognised for that expected reimbursement. In extremely rare cases, disclosure of some or all of the information required by IAS 37 paras 84-85 (paras 1 and 3 above) can be expected to prejudice the position of the entity in a dispute with other parties in respect of the matter for which the provision is made. In such a situation, the information does not need to be disclosed, but the following should be disclosed: (a) the general nature of the dispute; (b) the fact that the information has not been disclosed; and (c) the reason why that information has not been disclosed. If an estimate of an amount reported in an interim period for example, a provision is changed signicantly during the nal interim period of the nancial year but a separate nancial report is not published for that nal interim period, the nature and amount of that change in estimate should be disclosed in a note to the annual nancial statements for that nancial year. This item is applicable only when the reporting entity publishes an interim nancial report prepared in accordance with IAS 34.
37p85
3.
37p92
4.
34p26
5.
19p120A(b)
2.
19p120A(c) 3.
PricewaterhouseCoopers
Y-NA-NM
REF
(a) (b) (c) (d) (e) (f) (g) (h) (i) 19p120A(d) 4.
current service cost; interest cost; actuarial gains and losses; foreign currency exchange rate changes on plans measured in a currency different from the entitys presentation currency; benets paid; past service cost; business combinations; curtailments; and settlements.
Provide an analysis of the dened benet obligation into amounts arising from plans that are wholly unfunded and amounts arising from plans that are wholly or partly funded. Provide a reconciliation of the opening and closing balances of the fair value of plan assets and of the opening and closing balances of any reimbursement right recognised as an asset in accordance with IAS 19 para 104A, showing separately, if applicable, the effects during the period attributable to each of the following: (a) expected return on plan assets; (b) actuarial gains and losses; (c) foreign currency exchange rate changes on plans measured in a currency different from the entitys presentation currency; (d) contributions by the employer; (e) contributions by plan participants; (f) benets paid; (g) business combinations; and (h) settlements. Provide a reconciliation of the present value of the dened benet obligation in para 2 above, and the fair value of the plan assets in para 4 above, to the assets and liabilities recognised in the balance sheet, showing at least: (a) the net actuarial gains or losses not recognised in the balance sheet; (b) the past service cost not recognised in the balance sheet (refer to IAS 19 para 96); (c) any amount not recognised as an asset, because of the limit in IAS 19 para 58(b); (d) the fair value at the balance sheet date of any reimbursement right recognised as an asset in accordance with IAS 19 para 104A (with a brief description of the link between the reimbursement right and the related obligation); and (e) the other amounts recognised in the balance sheet. Provide the total expense recognised in prot or loss for each of the following, and the line item(s) in which they are included: (a) current service cost; (b) interest cost; (c) expected return on plan assets; (d) expected return on any reimbursement right recognised as an asset in accordance with IAS 19 para 104A; (e) actuarial gains and losses; (f) past service cost; (g) the effect of any curtailment or settlement; and (h) the effect of the limit in IAS 19 para 58(b).
19p120A(e)
5.
19p120A(f)
6.
19p120A(g)
7.
PricewaterhouseCoopers
39
Section A5
Y-NA-NM
REF
19p120A(h) 1p96(b)
8.
Provide the total amount recognised in the statement of recognised income and expense for each of the following: (a) actuarial gains and losses; and (b) the effect of the limit in IAS 19 para 58(b). The cumulative amount of actuarial gains and losses recognised in the statement of recognised income and expense.
9.
10. Provide for each major category of plan assets which should include, but is not limited to, equity instruments, debt instruments, property, and all other assets the percentage or amount that each major category constitutes of the fair value of the total plan assets. 11. Provide the amounts included in the fair value of plan assets for: (a) each category of the entitys own nancial instruments; and (b) any property occupied by, or other assets used by, the entity. 12. Provide a narrative description of the basis used to determine the overall expected rate of return on assets, including the effect of the major categories of plan assets.
19p120A(k)
19p120A(l)
19p120A(m) 13. Provide the actual return on plan assets, as well as the actual return on any reimbursement right recognised as an asset in accordance with IAS 19 para 104A. 19p120A(n) 14. Provide the principal actuarial assumptions used as at the balance sheet date, including, when applicable: (a) the discount rates; (b) the expected rates of return on any plan assets for the periods presented in the nancial statements; (c) the expected rates of return for the periods presented in the nancial statements on any reimbursement right recognised as an asset in accordance with para 104A; (d) the expected rates of salary increases (and of changes in an index or other variable specied in the formal or constructive terms of a plan as the basis for future benet increases); (e) medical cost trend rates; and (f) any other material actuarial assumptions used (such as details of mortality assumptions). Disclose each actuarial assumption in absolute terms (for example, as an absolute percentage), not just as a margin between different percentages or other variables. 19p120A(o) 15. Provide the effect of an increase of one percentage point and the effect of a decrease of one percentage point in the assumed medical cost trend rates on: (a) the aggregate of the current service cost and interest cost components of net periodic post-employment medical costs; and (b) the accumulated post-employment benet obligation for medical costs. All other assumptions should be held constant for the purposes of this disclosure. For plans operating in a high ination environment, the disclosure should be the effect of a percentage increase or decrease in the assumed medical cost trend rate of a signicance similar to one percentage point in a low ination environment.
40
PricewaterhouseCoopers
Y-NA-NM
REF
19p120A(p)
16. Provide the amounts for the current annual period and previous four annual periods of: (a) the present value of the dened benet obligation, the fair value of the plan assets and the surplus or decit in the plan; and (b) the experience adjustments arising on: (i) the plan liabilities expressed either as (1) an amount, or (2) a percentage of the plan liabilities at the balance sheet date; and (ii) the plan assets expressed either as (1) an amount, or (2) a percentage of the plan assets at the balance sheet date. 17. Provide the employers best estimate, as soon as it can reasonably be determined, of contributions expected to be paid to the plan during the annual period beginning after the balance sheet date. 18. For multi-employer plans that are treated as dened benet plans, disclose the information required by IAS 19 para 120A. 19. For multi-employer plans that are treated as a dened contribution plan, disclose; (a) the fact that the plan is a dened benet plan; (b) the reason why sufcient information is not available to enable the entity to account for the plan as a dened benet plan; (c ) to the extent that a surplus or decit in the plan may affect the amount of future contribution: (i) any available information about that surplus or decit; (ii) the basis used to determine that surplus or decit; and (iii) the implications, if any, for the entity (refer also to IAS 19 para 32A and 32B).
19p120A(q)
19p29(b) 19p30(b)(c)
19p34B(a-d) 20. For a dened benet plan that shares risks between entities under common control, disclose; (a) the contractual agreement or stated policy for charging the dened benet cost or the fact that there is no such policy; (b) the policy for determining the contribution to be paid by the entity; (c) if the entity accounts for an allocation of the net dened benet cost in accordance with IAS 19 para 34A, all the information about the plan as a whole in accordance with paras 120-121 (paras 1-17 above); and (d) if the entity accounts for the contribution payable for the period in accordance with IAS 19 para 34A, information about the plan as a whole required in accordance with IAS 19 paras 120A (b)-(e), (j), (n), (o), (q) and 121 (paras 1-4, 9, 13, 14 and 16 above).
PricewaterhouseCoopers
41
Section A5
Y-NA-NM
REF
(c) the total of minimum lease payments at the balance sheet date, and their present value, for each of the following periods: (i) no later than one year; (ii) later than one year but no later than ve years; and (iii) later than ve years; (d) the amount of contingent rents recognised in the income statement for the period; (e) the total of future minimum sublease payments expected to be received under non-cancellable subleases at the balance sheet date; and (f) a general description of the lessees signicant leasing arrangements. This would include, but is not limited to: (i) the basis on which contingent rent payments are determined; (ii) the existence and terms of renewal or purchase options and escalation clauses; and (iii) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt and further leasing. The disclosure requirements of IAS 16, IAS 36, IAS 38, IAS 40 and IAS 41 apply to lessees for assets leased under nance leases. (b) Lessees operating leases 17p35 1. Disclose: (a) the total of future minimum lease payments under noncancellable operating leases for each of the following periods: (i) no later than one year; (ii) later than one year and no later than ve years; and (iii) later than ve years. (b) the total of future minimum sublease payments to be received under non-cancellable subleases at the balance sheet date; (c) lease and sublease payments recognised in the income statement for the period, with separate amounts for minimum lease payments, contingent rents and sublease payments; and (d) a general description of the lessees signicant leasing arrangements. This would include, but is not limited to: (i) the basis on which contingent rent payments are determined; (ii) the existence and terms of renewal or purchase options and escalation clauses; and (iii) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt and further leasing. The disclosure requirements about leases set out in Section A5.18 also apply to sale and leaseback transactions. Any unique or unusual provisions in the agreements or terms of the sale and leaseback transactions should be separately disclosed. The disclosure requirements set out in Section A5.18 also apply to leases under IFRIC 4. If a purchaser/lessee concludes that it is impractical to separate the lease payments in an operating lease reliably from other payments, it should treat all payments under the agreement as lease payments for the purpose of complying with the disclosures of IAS 17, but: (a) disclose those payments separately from minimum lease payments that do not include payments for non-lease elements; and
17p65
2.
IFRIC4pBC39 3. IFRIC4p15(b) 4.
PricewaterhouseCoopers
Y-NA-NM
REF
(b) state that the disclosed payments also include payments for non-lease elements in the arrangement. (c) Arrangements that do not involve a lease in substance SIC27p10-11 1. For arrangements that do not involve a lease in substance, disclose the following, individually for each arrangement or in aggregate for each class of arrangement, in each period in which an arrangement exists: (a) a description of the arrangement including: (i) the underlying asset and restrictions on its use; (ii) the life and other signicant terms of the arrangement; (iii) the transactions that are linked together, including any options; and (b) the accounting treatment applied to any fee received, the amount recognised in income in the period, and the line item of the income statement in which it is included.
32p28
3.
PricewaterhouseCoopers
43
Section A5
Y-NA-NM
REF
(f) joint ventures; (g) the entitys or parents key management personnel; (h) close members of the family of any individual referred to in (a), (b), (c), (d) or (g); (i) an entity that is controlled, jointly controlled or signicantly inuenced by any individual referred to in (g) or (h), or for which signicant voting power in the entity resides with, directly or indirectly, any individual referred to in (g) or (h); and (j) the post-employment benet plan. 24p12 2. Relationships between parents and subsidiaries should be disclosed irrespective of whether there have been transactions between those related parties. Disclose the name of the entitys parent and, if different, the ultimate controlling party. If neither the entitys parent nor the ultimate controlling party produces nancial statements available for public use, the name of the next most senior parent that does so should also be disclosed. Key management personnel compensation should be disclosed in total and for each of the following categories: (a) short-term employee benets; (b) post-employment benets; (c) other long-term benets; (d) termination benets; and (e) share-based payments. Where there have been transactions between related parties, disclose: (a) the nature of related-party relationships; (b) types of transactions (for example, goods or services sold/purchased, management services, directors remuneration and emoluments, loans and guarantees); (c) the amount of transactions; (d) the amount of outstanding balances (including terms and conditions, secured or not, the nature of the consideration to be provided in settlement and any guarantees given or received); (e) provisions for doubtful debts related to the amount of outstanding balances; and (f) the expense recognised during the period in respect of bad or doubtful debts due from related parties. The disclosures required by paragraph 4 above should be made separately for each of the following categories: (a) the parent; (b) entities with joint control or signicant inuence over the entity; (c) subsidiaries; (d) associates; (e) joint ventures in which the entity is a venturer; (f) entitys or parents key management personnel; and (g) other related parties. IAS 24 para 20 contains examples of situations that may require disclosure. Where necessary for an understanding of the effects of related-party transactions on the nancial statements, disclose items of similar nature separately, rather than in aggregate. Only provide disclosures that related-party transactions were made on an arms length basis if such terms can be substantiated.
24p16
3.
24p17(a-d)
4.
24p18
5.
24p20 24p22
6. 7.
24p21
8.
PricewaterhouseCoopers
Y-NA-NM
REF
32p34
9.
Separately provide disclosures where the entity re-acquires its own equity instruments from related parties, in accordance with IAS 24 para 22.
19p34B
10. Participation in a dened benet plan that shares risks between various entities under common control (for example,. a parent and its subsidiaries) is a related-party transaction for each individual group entity. Make the following disclosures in the separate or individual nancial statements: (a) the contractual agreement or stated policy for charging the net dened benet cost or the fact that there is no such policy; (b) the policy for determining the contribution to be paid by the entity; (c) if the entity accounts for an allocation of the net dened benet cost in accordance with IAS 19 paragraph 34A, all the information about the plan as a whole in accordance with IAS 19 paragraphs 120-121; and (d) if the entity accounts for the contribution payable for the period in accordance with IAS 19 paragraph 34A, the information about the plan as a whole required in accordance with IAS 19 paragraphs 120A(b)-(e), (j), (n), (o), (q) and 121. The other disclosures required by paragraph 120A do not apply.
22. Commitments
1. 16p74(c) 38p122(e) 40p75(h) 2. The amount of contractual commitments for the acquisition of: (a) property, plant and equipment; and (b) intangible assets. Contractual obligations: (a) to purchase, construct or develop investment property; and (b) for repairs, maintenance or enhancements of investment property.
Refer also to the commitments in respect of lease agreements in Section A5.18 and commitments in respect of joint ventures in Section A5.9.
23. Contingencies
37p86 1. Disclose for each class of contingent liability, unless the possibility of any outow in settlement is remote: (a) a brief description of the nature of the contingent liability; (b) where practicable, disclose also: (i) an estimate of its nancial effect, measured under IAS 37 paras 36-52; (ii) an indication of the uncertainties about the amount or timing of any outow; and (iii) the possibility of any reimbursement; and (c) where any of this information is not disclosed because it is not practicable to do so, disclose that fact. Where a provision and a contingent liability arise from the same set of circumstances, the link between the provision and the contingent liability should be shown. Disclose for contingent assets, where an inow of economic benets is probable: (a) a brief description of the nature of the contingent asset; (b) where practicable, an estimate of their nancial effect, measured under IAS 37 paras 36-52; and (c) where this information is not disclosed because it is not practicable to do so, disclose that fact.
PricewaterhouseCoopers 45
37p89
3.
37p91
Section A5
Y-NA-NM
REF
37p92
4.
In extremely rare cases, disclosure of some or all of the information required by IAS 37 paras 86-89 on contingencies (paras 1 to 3 above) can be expected to seriously prejudice the position of the entity in a dispute with other parties on the subject of the contingent liability or contingent asset. In such cases, the information need not be disclosed, but the following must be disclosed: (a) the general nature of the contingencies; (b) the fact that the required information has not been disclosed; and (c) the reason why the required information has not been disclosed. Disclose contingent liabilities arising from: (a) post-employment benet obligations; and (b) termination benets (for example, due to the uncertainty over the number of employees who will accept an offer of termination benets). Refer also to Sections A5.17(a) para 8 and A5.17(b) para 18. Refer also to the contingencies in respect of lease agreements in Section A5.18 and contingencies in respect of joint ventures in Section A5.9.
5. 19p125 19p141
10p21
2.
33p64
4.
Y-NA-NM
REF
33p70(d)
5.
Provide a description of ordinary share transactions or potential ordinary share transactions other than capitalisation, bonus issues or share splits, for which the basic and diluted earnings per share are adjusted retrospectively that occur after the balance sheet date and that would have changed signicantly the number of ordinary shares or potential ordinary shares outstanding at the end of the period if those transactions had occurred before the end of the reporting period. Examples are provided in IAS 33 para 71.
12p81(i)
6.
Disclose the amount of income tax consequences of dividends that were proposed or declared after the balance sheet date but before the nancial statements were authorised for issue. If income taxes are payable at a higher or lower rate if part or all of the net prot or retained earnings is paid out as a dividend to shareholders, disclose: (a) the nature of the potential income tax consequences that would result from the payment of dividends; and (b) the amounts of the potential income tax consequences practically determinable and whether there are any potential income tax consequences not practically determinable. If an entity receives information after the balance sheet date about conditions that existed at the balance sheet date, update the disclosures that relate to those conditions in the light of the new information.
12p82A
7.
10p19
8.
A6 Cash ow statement
1. General presentation
7, AppA 7p10 7p18 For example cash ow statements (direct and indirect method), refer to IAS 7 Appendix A. 1. 2. Classify cash ows into three activities: operating, investing and nancing activities. Disclose cash ows from operating activities using either: (a) the direct method, disclosing major classes of gross cash receipts or payments; or (b) the indirect method, adjusting net prot and loss for the effects of: (i) any transactions of a non-cash nature; (ii) any deferrals or accruals of past or future operating cash receipts or payments; and (iii) items of income or expense associated with investing or nancing cash ows. For cash ows from investing and nancing activities, disclose separately major classes of gross cash receipts and gross cash payments (except as noted in para 4 below). For example, proceeds from new borrowings have to be displayed separately from repayments of borrowings. The following cash ows arising from the operating, investing or nancing activities may be reported on a net basis (IAS 7 para 23): (a) cash receipts and payments on behalf of customers when the cash ows reect the activities of the customer rather than those of the entity; and (b) cash receipts and payments for items in which the turnover is quick, the amounts are large and the maturities are short.
7p21
3.
7p22
4.
PricewaterhouseCoopers
47
Section A6
Y-NA-NM
REF
7p43
5.
For non-cash transactions, exclude from the cash ow statement those investing and nancing transactions that do not require the use of cash and cash equivalents. Disclose non-cash transactions separately in the note to the cash ow statement. Examples of non-cash transactions are: (a) acquisition of assets either by assuming directly related liabilities or by means of a nance lease; (b) acquisition of an entity by means of an equity issue; and (c) conversion of debt to equity.
7p44
2. Individual items
1. 7p35 7p36 For cash ows arising from taxes on income: (a) disclose taxes paid; (b) classify taxes paid as cash ows from operating activities unless specically identied with nancing and investing activities; and (c) disclose the total amount of taxes paid when tax cash ows are allocated over more than one class of activity. For cash ows from interest and dividends, disclose: (a) interest received; (b) interest paid; (c) dividends received; and (d) dividends paid. Each of the above items should be classied in a consistent manner from period to period as either operating, investing or nancing activities. 7p33 7p34 7p39 3. Interest paid is normally classied as either operating or nancing activities. Interest and dividends received are normally classied as either operating or investing activities. Dividends paid are normally classied as either nancing or operating activities. Aggregate cash ows arising from the following are presented separately and classied as investing activities: (a) acquisitions; and (b) disposals of subsidiaries or other business units. Refer also to the disclosure requirements for acquisitions and disposals in Section A7. 7p45 4. For cash and cash equivalents, disclose: (a) the components; and (b) reconciliation of amounts in cash ow statement with cash and cash equivalents in the balance sheet. Disclose the amount of signicant cash and cash equivalent balances held by the entity that are not available for use by the group, and provide a commentary by management. Discontinued operation disclose the amounts of net cash ows from: (a) operating activities; (b) investing activities; and (c) nancing activities. These disclosures may be presented either in the notes to, or on the face of, the nancial statements. DV7p50 7. Voluntary disclosures provide additional information relevant to understanding the nancial position and liquidity of an entity, and a commentary by management:
7p31
2.
7p48
5.
IFRS5p33(c) 6.
48
PricewaterhouseCoopers
Y-NA-NM
REF
(a) the amount of undrawn borrowing facilities available for future operating activities and to settle capital commitments, indicating any restrictions as to the use of these facilities; (b) the aggregate amounts of the cash ows from each of operating, investing and nancing activities related to interests in joint ventures reported using proportionate consolidation; (c) the aggregate amount of cash ows that represent increases in operating capacity separately from those cash ows that are required to maintain operating capacity; and (d) the amount of cash ows arising from the operating, investing and nancing activities of each reported industry and geographical segment.
Section A7
Y-NA-NM
REF
(i) the amount of the acquirees prot or loss since the acquisition date included in the acquirers prot or loss for the period, unless impracticable. If such disclosure would be impracticable, that fact should be disclosed, together with an explanation of why this is the case. IFRS3p66(b) All relevant disclosures required by IFRS 3 should also be made for business combinations after the balance sheet date and before the date on which the nancial statements are issued; if it is impracticable to disclose any of this information, disclose this fact together with an explanation of why this is the case. 2. Disclose the information required under IFRS 3 para 67 (refer to para 1 above) in aggregate for business combinations that took effect during the reporting period and that are individually immaterial. In respect of acquisitions of subsidiaries or other business units, disclose in aggregate: (a) the total purchase consideration; (b) the portion of the total purchase consideration discharged by means of cash and cash equivalents; (c) the amount of cash and cash equivalents in the subsidiary or business unit acquired; and (d) the amount of the assets and liabilities other than cash or cash equivalents in the subsidiary or business unit acquired, summarised by each major category. If the initial accounting for a business combination that took effect during the reporting period has been determined only provisionally, that fact should be disclosed, together with an explanation of why this is the case, as described in IFRS 3 para 62. The acquirer should also disclose: (a) the revenue of the combined entity for the period as if the acquisition date for all business combinations that took effect during the reporting period had been at the beginning of that period; and (b) the prot or loss of the combined entity for the period as if the acquisition date for all business combinations that took effect during the reporting period had been at the beginning of that period. If disclosure of this information would be impracticable, disclose that fact, together with an explanation of why this is the case. IFRS3p73 6. The acquirer should also disclose the following information relating to business combinations that took effect in the current or previous periods: (a) the amount and an explanation of any material gain or loss recognised in the current reporting period; (b) the amounts and explanations of the adjustments to the provisional values recognised during the current reporting period; and (c) the information about error corrections that the acquirer recognises during the current reporting period, as required by IAS 8.
IFRS3p68
7p40
3.
IFRS3p69
4.
5. IFRS3p70
2. Disposals
7p40 1. In respect of disposals of subsidiaries or other business units, disclose in aggregate: (a) the total disposal consideration;
PricewaterhouseCoopers
Y-NA-NM
REF
(b) the portion of the total disposal consideration discharged by means of cash and cash equivalents; (c) the amount of cash and cash equivalents in the subsidiary or business unit disposed of; and (d) the amount of the assets and liabilities other than cash or cash equivalents in the subsidiary or business unit disposed of, summarised by each major category.
A8 Financial instruments
1. General disclosures
IFRS7p6 AppxB1-B3 When IFRS 7 requires disclosures by class of nancial instrument, group the nancial instruments into classes that are appropriate to the nature of the information disclosed. Take into account the characteristics of those nancial instruments. Provide sufcient information to permit reconciliation to the line items presented in the balance sheet. Disclose information that enables users of the nancial statements to evaluate the signicance of nancial instruments for nancial position and performance.
IFRS7p7
PricewaterhouseCoopers
51
Section A8
Y-NA-NM
REF
(ii) using an alternative method that the entity believes more faithfully represents the amount of change in its fair value that is attributable to changes in the credit risk of the asset. Changes in market conditions that give rise to market risk include changes in an observed (benchmark) interest rate, commodity price, foreign exchange rate or index of prices or rates; and (d) the amount of the change in the fair value of any related credit derivatives or similar instruments that has occurred during the period and cumulatively since the loan or receivable was designated. IFRS7p10 AppxB4 2. If the entity has designated a nancial liability as at fair value through prot or loss in accordance with IAS 39p9, disclose: (a) the amount of change, during the period and cumulatively, in the fair value of the nancial liability that is attributable to changes in the credit risk of that liability determined either: (i) as the amount of change in its fair value that is not attributable to changes in market conditions that give rise to market risk (see IFRS7AppdxB4); or (ii) using an alternative method that the entity believes more faithfully represents the amount of change in its fair value that is attributable to changes in the credit risk of the liability. Changes in market conditions that give rise to market risk include changes in a benchmark interest rate, the price of another entitys nancial instrument, a commodity price, a foreign exchange rate or an index of prices or rates. For contracts that include a unit-linking feature, changes in market conditions include changes in the performance of the related internal or external investment fund; and (b) the difference between the nancial liabilitys carrying amount and the amount the entity would be contractually required to pay at maturity to the holder of the obligation. Disclose: (a) the methods used to comply with the requirements in IFRS7p9(c) and IFRS7p10(a); and (b) if the entity believes that the disclosure it has given to comply with the requirements in IFRS7p9(c) and IFRS7p10(a) does not faithfully represent the change in the fair value of the nancial asset or nancial liability attributable to changes in its credit risk, the reasons for reaching this conclusion and the factors it believes are relevant.
IFRS7p11 AppxB4
3.
4. Reclassication
IFRS7p12 If the entity has reclassied a nancial asset as one measured: (a) at cost or amortised cost, rather than at fair value; or (b) at fair value, rather than at cost or amortised cost, disclose the amount reclassied into and out of each category and the reason for that reclassication (see IAS39p51-54).
5. Derecognition
IFRS7p13 If nancial assets have been transferred in such a way that part or all of the nancial assets do not qualify for derecognition (see 39p15-37), disclose for each class of such nancial assets: (a) the nature of the assets;
PricewaterhouseCoopers
Y-NA-NM
REF
(b) the nature of the risks and rewards of ownership to which the entity remains exposed; (c) when the entity continues to recognise all of the assets, the carrying amounts of the assets and of the associated liabilities; and (d) when the entity continues to recognise the assets to the extent of its continuing involvement, the total carrying amount of the original assets, the amount of the assets that the entity continues to recognise, and the carrying amount of the associated liabilities.
6. Collateral
IFRS7p14 1. Disclose: (a) the carrying amount of nancial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassied in accordance with IAS39p37(a); and (b) the terms and conditions relating to its pledge. When the entity holds collateral (of nancial or non-nancial assets) and is permitted to sell or repledge the collateral in the absence of default by the owner of the collateral, disclose: (a) the fair value of the collateral held; (b) the fair value of any such collateral sold or repledged, and whether the entity has an obligation to return it; and (c) the terms and conditions associated with its use of the collateral.
IFRS7p15
2.
PricewaterhouseCoopers
53
Section A8
Y-NA-NM
REF
IFRS7p19
2.
If during the period there were breaches of loan agreement terms other than those described in IFRS7p18, disclose the same information as required by IFRS7p18 if those breaches permitted the lender to demand accelerated repayment (unless the breaches were remedied, or the terms of the loan were renegotiated, on or before the reporting date).
IFRS7 AppxB5
54
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS7p10
(e)
(f)
(g)
(iii) how the entity has satised the conditions in IAS39p9, IAS39p11A or IAS39p12 for such designation. For instruments designated in accordance with IAS39p9(b)(i) of the denition of a nancial asset or nancial liability at fair value through prot or loss, include a narrative description of the circumstances underlying the measurement or recognition inconsistency that would otherwise arise. For instruments designated in accordance with IAS39p9(b)(ii) of the denition of a nancial asset or nancial liability at fair value through prot or loss, include a narrative description of how designation at fair value through prot or loss is consistent with the entitys documented risk management or investment strategy; the criteria for designating nancial assets as available for sale; whether regular way purchases and sales of nancial assets are accounted for at trade date or at settlement date (see IAS39p38). when an allowance account is used to reduce the carrying amount of nancial assets impaired by credit losses: (i) the criteria for determining when the carrying amount of impaired nancial assets is reduced directly (or, in the case of a reversal of a write-down, increased directly) and when the allowance account is used; and (ii) the criteria for writing off amounts charged to the allowance account against the carrying amount of impaired nancial assets; how net gains or net losses on each category of nancial instrument are determined (see IFRS7p20(a)), for example, whether the net gains or net losses on items at fair value through prot or loss include interest or dividend income; the criteria the entity uses to determine that there is objective evidence that an impairment loss has occurred (see IFRS7p20(e)); and when the terms of nancial assets that would otherwise be past due or impaired have been renegotiated, the accounting policy for nancial assets that are the subject of renegotiated terms (see IFRS7p36(d)).
Disclose, in the summary of signicant accounting policies or other notes, the judgements, apart from those involving estimations, that management has made in the process of applying the entitys accounting policies and that have the most signicant effect on the amounts recognised in the nancial statements (see IAS1p113). IFRS7p22 (b) Hedge accounting Disclose the following separately for each type of hedge described in IAS 39 (ie, fair value hedges, cash ow hedges and hedges of net investments in foreign operations): (a) a description of each type of hedge; (b) a description of the nancial instruments designated as hedging instruments and their fair values at the reporting date; and (c) the nature of the risks being hedged. For cash ow hedges, disclose: (a) the periods when the cash ows are expected to occur and when they are expected to affect prot or loss; (b) a description of any forecast transaction for which hedge accounting had previously been used, but which is no longer expected to occur;
IFRS7 p23
PricewaterhouseCoopers
55
Section A8
Y-NA-NM
REF
(c) the amount that was recognised in equity during the period; (d) the amount that was removed from equity and included in prot or loss for the period, showing the amount included in each line item in the income statement; and (e) the amount that was removed from equity during the period and included in the initial cost or other carrying amount of a non-nancial asset or non-nancial liability whose acquisition or incurrence was a hedged highly probable forecast transaction. IFRS7 p24 Disclose separately: (a) in fair value hedges, gains or losses: (i) on the hedging instrument; and (ii) on the hedged item attributable to the hedged risk; (b) the ineffectiveness recognised in prot or loss that arises from cash ow hedges; and (c) the ineffectiveness recognised in prot or loss that arises from hedges of net investments in foreign operations. (c) Fair value Except as set out in IFRS7p29, for each class of nancial assets and nancial liabilities (see IFRS7p6), disclose the fair value of that class of assets and liabilities in a way that permits it to be compared with its carrying amount. In disclosing fair values, group nancial assets and nancial liabilities into classes, but offset them only to the extent that their carrying amounts are offset in the balance sheet. Disclose: (a) the methods and, when a valuation technique is used, the assumptions applied in determining fair values of each class of nancial asset or nancial liability. For example, if applicable, disclose information about the assumptions relating to prepayment rates, rates of estimated credit losses, and interest rates or discount rates; (b) whether fair values are determined, in whole or in part, directly by reference to published price quotations in an active market or are estimated using a valuation technique (see IAS39AG71-AG79); (c) whether the fair values recognised or disclosed in the nancial statements are determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable current market transactions in the same instrument (ie, without modication or repackaging) and not based on available observable market data. For fair values that are recognised in the nancial statements, if changing one or more of those assumptions to reasonably possible alternative assumptions would change the fair value signicantly, state this fact and disclose the effect of those changes. For this purpose, judge the signicance with respect to prot or loss, and total assets or total liabilities, or, when changes in fair value are recognised in equity, total equity; and (d) if (c) applies, the total amount of the change in fair value estimated using such a valuation technique that was recognised in prot or loss during the period. If the market for a nancial instrument is not active, its fair value is established using a valuation technique (see IAS39AG74-AG79). The best evidence of fair value at initial recognition is the transaction price (ie, the fair value of the consideration given or received), unless conditions
IFRS7p25
IFRS7p26
IFRS7 p27
IFRS7p28
PricewaterhouseCoopers
Y-NA-NM
REF
described in IAS39AG76 are met. There could be a difference between the fair value at initial recognition and the amount that would be determined at that date using the valuation technique. If such a difference exists, disclose, by class of nancial instrument: (a) the accounting policy for recognising that difference in prot or loss to reect a change in factors (including time) that market participants would consider in setting a price (see IAS39AG76A); and (b) the aggregate difference yet to be recognised in prot or loss at the beginning and end of the period and a reconciliation of changes in the balance of this difference. IFRS7p29 Disclosures of fair value are not required: (a) when the carrying amount is a reasonable approximation of fair value (for example, for nancial instruments such as short-term trade receivables and payables); (b) for an investment in equity instruments that do not have a quoted market price in an active market, or derivatives linked to such equity instruments, that is measured at cost in accordance with IAS 39 because its fair value cannot be measured reliably; or (c) for a contract containing a discretionary participation feature (as described in IFRS 4) if the fair value of that feature cannot be measured reliably. In the cases described in IFRS7p29(b) and (c), disclose information to help users of the nancial statements make their own judgements about the extent of possible differences between the carrying amount of those nancial assets or nancial liabilities and their fair value, including: (a) the fact that fair value information has not been disclosed for these instruments because their fair value cannot be measured reliably; (b) a description of the nancial instruments, their carrying amount, and an explanation of why fair value cannot be measured reliably; (c) information about the market for the instruments; (d) information about whether and how the entity intends to dispose of the nancial instruments; and (e) if nancial instruments whose fair value previously could not be reliably measured are derecognised, that fact, their carrying amount at the time of derecognition, and the amount of gain or loss recognised.
IFRS7p30
IFRS7 AppdxB6
IFRS7p32
PricewaterhouseCoopers
57
Section A8
Y-NA-NM
REF
IFRS7 AppdxB8
IFRS7p37
58
PricewaterhouseCoopers
Y-NA-NM
REF
by the entity as security and other credit enhancements and, unless impracticable, an estimate of their fair value. Collateral and other credit enhancements obtained When an entity obtains nancial or non-nancial assets during the period by taking possession of collateral it holds as security or calling on other credit enhancements (for example, guarantees), and such assets meet the recognition criteria in other standards, disclose: (a) the nature and carrying amount of the assets obtained; and (b) when the assets are not readily convertible into cash, the policies for disposing of such assets or for using them in its operations. Disclose: (a) a maturity analysis for nancial liabilities that shows the remaining contractual maturities; and (b) a description of how the liquidity risk inherent in (a) is managed. In preparing the contractual maturity analysis for nancial liabilities required by IFRS7p39(a), use judgement to determine an appropriate number of time bands. For example, an entity might determine that the following time bands are appropriate: (a) not later than one month; (b) later than one month and not later than three months; (c) later than three months and not later than one year; and (d) later than one year and not later than ve years. When a counterparty has a choice of when an amount is paid, include the liability on the basis of the earliest date on which the entity can be required to pay. For example, nancial liabilities that an entity can be required to repay on demand (for example, demand deposits) are included in the earliest time band. IFRS7 AppdxB13 When an entity is committed to make amounts available in instalments, allocate each installment to the earliest period in which the entity can be required to pay. For example, include an undrawn loan commitment in the time band containing the earliest date it can be drawn down The amounts disclosed in the maturity analysis are the contractual undiscounted cash ows, for example: (a) gross nance lease obligations (before deducting nance charges); (b) prices specied in forward agreements to purchase nancial assets for cash; (c) net amounts for pay-oating/receive-xed interest rate swaps for which net cash ows are exchanged; (d) contractual amounts to be exchanged in a derivative nancial instrument (for example, a currency swap) for which gross cash ows are exchanged; and (e) gross loan commitments. Such undiscounted cash ows differ from the amount included in the balance sheet because the balance sheet amount is based on discounted cash ows. IFRS7 AppdxB15 If appropriate, disclose the analysis of derivative nancial instruments separately from that of non-derivative nancial instruments in the contractual maturity analysis for nancial liabilities required by IFRS7p39(a). For example, it would be appropriate to distinguish cash
PricewaterhouseCoopers 59
IFRS7p38
IFRS7p39
IFRS7p40 AppdxB11
IFRS7 AppdxB14
Section A8
Y-NA-NM
REF
ows from derivative nancial instruments and non-derivative nancial instruments if the cash ows arising from the derivative nancial instruments are settled gross. This is because the gross cash outow may be accompanied by a related inow. IFRS7 AppdxB16 When the amount payable is not xed, determine the amount disclosed by reference to the conditions existing at the reporting date. For example, when the amount payable varies with changes in an index, the amount disclosed may be based on the level of the index at the reporting date. (b) Market risk Sensitivity analysis Unless an entity complies with IFRS7p41, disclose: (a) a sensitivity analysis for each type of market risk to which the entity is exposed at the reporting date, showing how prot or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date; (b) the methods and assumptions used in preparing the sensitivity analysis; and (c) changes from the previous period in the methods and assumptions used, and the reasons for such changes. If the entity prepares a sensitivity analysis, such as value at risk, that reects interdependencies between risk variables (for example, interest rates and exchange rates) and uses it to manage nancial risks, it may use that sensitivity analysis in place of the analysis specied in IFRS7p40. Also disclose: (a) an explanation of the method used in preparing such a sensitivity analysis, and of the main parameters and assumptions underlying the data provided; and (b) an explanation of the objective of the method used and of limitations that may result in the information not fully reecting the fair value of the assets and liabilities involved. Other market risk disclosures When the sensitivity analyses disclosed in accordance with IFRS7p40 or IFRS7p41 are unrepresentative of a risk inherent in a nancial instrument (for example, because the year-end exposure does not reect the exposure during the year), disclose that fact and the reason the sensitivity analyses are unrepresentative. Apply IFRS 7 for annual periods beginning on or after 1 January 2007. Earlier application is encouraged. If an entity applies this IFRS for an earlier period, disclose that fact.
IFRS7p40 AppdxB17-28
IFRS7p41 AppdxB17-28
IFRS7p42
IFRS7p42
1p124B
PricewaterhouseCoopers
Y-NA-NM
REF
(b)
requirements are incorporated into the management of capital; and (iii) how it is meeting its objectives for managing capital; summary quantitative data about what it manages as capital. Some entities regard some nancial liabilities (for example, some forms of subordinated debt) as part of capital. Other entities regard capital as excluding some components of equity (for example, components arising from cash ow hedges); any changes in (a) and (b) from the previous period; whether during the period it complied with any externally imposed capital requirements to which it is subject; and when the entity has not complied with such externally imposed capital requirements, the consequences of such non-compliance.
These disclosures should be based on the information provided internally to the entitys key management personnel. 1p124C An entity may manage capital in a number of ways and be subject to a number of different capital requirements. For example, a conglomerate may include entities that undertake insurance activities and banking activities, and those entities may also operate in several jurisdictions. When an aggregate disclosure of capital requirements and how capital is managed would not provide useful information or distorts a nancial statement users understanding of an entitys capital resources, the entity should disclose separate information for each capital requirement to which the entity is subject.
PricewaterhouseCoopers
61
Section A9
Y-NA-NM
REF
2.
IFRS5p38
3.
IFRS5p39
IFRS5p38
IFRS5p40
5.
IFRS5p41
6.
IFRS5p12
7.
IFRS5p42
8.
IFRS5p33
9.
62
PricewaterhouseCoopers
Y-NA-NM
REF
12p81(h)
(i) the post-tax prot or loss of discontinued operations; and (ii) the post-tax gain or loss recognised on the remeasurement to fair value less costs to sell or on the disposal of the assets or disposal group(s) constituting the discontinued operation; and (b) an analysis of the single amount in (a) above into: (i) the revenue, expenses and pre-tax prot or loss of discontinued operations; (ii) the related income tax expense as required by IAS 12 para 81(h); and (iii) the tax expense relating to: the gain or loss on discontinuance; the prot or loss from the ordinary activities of the discontinued operation for the period, together with the corresponding amounts for each prior period presented. The analysis may be given in the notes or on the face of the income statement. If it is given on the face of the income statement, it should be presented in a section relating to discontinued operations separate from continuing operations. The analysis is not required if the disposal group is a newly acquired subsidiary that meets the criteria to be classied as held for sale on acquisition.
IFRS5p34
10. Re-present the disclosures in para 7 above and Section A6.2 para 6 for prior periods presented in the nancial statements so that the disclosures relate to all operations that have been discontinued by the balance sheet date for the latest period presented. 11. Present separately in discontinued operations any adjustments in the current period to amounts previously presented in discontinued operations that are directly related to the disposal of a discontinued operation in a prior period. The nature and amount of such adjustments should be disclosed. 12. If a component of an entity ceases to be classied as held for sale, the results of operations of the component previously presented in discontinued operations should be reclassied and included in income from continuing operations for all periods presented. Disclose the amounts for prior periods as having been re-presented.
IFRS5p35
IFRS5p36
PricewaterhouseCoopers
63
64
PricewaterhouseCoopers
Section B Disclosures required for all entities but only in certain situations
PricewaterhouseCoopers
65
66
PricewaterhouseCoopers
Y-NA-NM
REF
8p49
29p39(b) 29p39(c)
3. 4.
29p9
5.
21p42
6.
PricewaterhouseCoopers
67
Section B Disclosures required for all entities but only in certain situations
Y-NA-NM
REF
21p43
7.
When an entity s functional currency is the currency of a hyperinflationary economy, the entity should restate its financial statements in accordance with IAS 29 before applying the translation method set out in IAS 21 para 42, except for comparative amounts that are translated into a currency of a non-hyperinflationary economy (refer to IAS 21 para 42(b)). When the economy ceases to be hyperinflationary and the entity no longer restates its financial statements in accordance with IAS 29, it should use as the historical costs to translate into the presentation currency the amounts restated to the price level at the date the entity ceased restating its financial statements.
Section B Disclosures required for all entities but only in certain situations
1p23
2.
2.
1p21
3.
68
PricewaterhouseCoopers
Y-NA-NM
REF
B5 Change of year-end
1p49 1. When an entity changes its year-end, and its nancial statements are presented for a period longer or shorter than one year, disclose: (a) the reason for a period other than one year being used; and (b) the fact that comparative amounts for the income statement, changes in equity, cash ows and related notes are not comparable.
27p41
B7 Share-based payments
IFRS2p44 1. Provide information that enables users of the nancial statements to understand the nature and extent of share-based payment arrangements that existed during the period. The entity should disclose at least the following: (a) a description of each type of share-based payment arrangement that existed at any time during the period, including the general terms and conditions of each arrangement, such as: (i) vesting requirements, (ii) the maximum term of options granted, (iii) the method of settlement (for example, whether in cash or equity). An entity with substantially similar types of share-based payment arrangements may aggregate this information, unless separate disclosure of each arrangement is necessary to enable users of the financial statements to understand the nature and extent of share-based payment arrangements that existed during the period.
IFRS2p45(a)
PricewaterhouseCoopers
69
Section B Disclosures required for all entities but only in certain situations
Y-NA-NM
REF
IFRS2p45(b)
IFRS2p45(c)
IFRS2p45(d)
(b) the number and weighted average exercise prices of share options for each of the following groups of options: (i) outstanding at the beginning of the period; (ii) granted during the period; (iii) forfeited during the period; (iv) exercised during the period; (v) expired during the period; (vi) outstanding at the end of the period; and (vii) exercisable at the end of the period. (c) the weighted average share price at the date of exercise for share options exercised during the period. The entity may instead disclose the weighted average share price during the period if options were exercised on a regular basis throughout the period. (d) for share options outstanding at the end of the period: (i) the range of exercise prices; and (ii) weighted average remaining contractual life. If the range of exercise prices is wide, the outstanding options should be divided into ranges that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. 2. Provide information that enables users of the nancial statements to understand how the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period was determined (refer to paras 3, 4 and 5 below). If the entity has measured the fair value of goods or services received as consideration for equity instruments of the entity indirectly, by reference to the fair value of the equity instruments granted, disclose at least the following: (a) for share options granted during the period, the weighted average fair value of those options at the measurement date and information on how that fair value was measured, including: (i) the option pricing model used and the inputs to that model, including: the weighted average share price, exercise price, expected volatility, option life, expected dividends, the risk-free interest rate, and any other inputs to the model, including the method used and the assumptions made to incorporate the effects of expected early exercise; (ii) how expected volatility was determined, including an explanation of the extent to which expected volatility was based on historical volatility; and (iii) whether and how any other features of the option grant were incorporated into the measurement of fair value, such as a market condition; (b) for other equity instruments granted during the period (other than share options), the number and weighted average fair value of those equity instruments at the measurement date, and information on how that fair value was measured, including:
Section B Disclosures required for all entities but only in certain situations
IFRS2p46
IFRS2p47
3.
IFRS2p47(a)
IFRS2p47(b)
70
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS2p47(c)
IFRS2p48
4.
If the entity has measured directly the fair value of goods or services received during the period, disclose how that fair value was determined; for example, whether fair value was measured at a market price for those goods or services. If the entity has rebutted the presumption that fair value of goods and services other than employee services can be estimated reliably, disclose that fact and give an explanation of why the presumption was rebutted. Provide information that enables users of the nancial statements to understand the effect of share-based payment transactions on the entitys prot or loss for the period and on its nancial position. At least the following should be disclosed: (a) the total expense recognised for the period arising from sharebased payment transactions in which the goods or services received did not qualify for recognition as assets and were recognised immediately as an expense, including separate disclosure of that portion of the total expense that arises from transactions accounted for as equity-settled share-based payment transactions; and (b) for liabilities arising from share-based payment transactions: (i) the total carrying amount at the end of the period; and (ii) the total intrinsic value at the end of the period of liabilities for which the counterpartys right to cash or other assets had vested by the end of the period (for example, vested share appreciation rights). Disclose additional information that is necessary to enable users of the nancial statements to understand the nature and extent of share-based payment arrangements that existed during the period, how fair value of the goods or services received or fair value of equity instruments granted during the period was determined and the effect of the share-based payment arrangements on prot or loss for the period and on nancial position.
IFRS2p49
5.
IFRS2p50
6.
IFRS2p51
IFRS2p52
7.
PricewaterhouseCoopers
71
Section B Disclosures required for all entities but only in certain situations
if fair value was not measured on the basis of an observable market price, how it was determined; (ii) whether and how expected dividends were incorporated into the measurement of fair value; and (iii) whether and how any other features of the equity instruments granted were incorporated into the measurement of fair value; and (c) for share-based payment arrangements that were modied during the period: (i) an explanation of those modications; (ii) the incremental fair value granted (as a result of those modications); and (iii) information on how the incremental fair value granted was measured, consistently with the requirements set out in (a) and (b) above, where applicable.
(i)
Y-NA-NM
REF
Section B Disclosures required for all entities but only in certain situations
IFRS1p39
2.
IFRS1p40
IFRS1p40 IFRS1p41
IFRS1p43
5.
72
PricewaterhouseCoopers
Y-NA-NM
REF
PricewaterhouseCoopers
73
Section B Disclosures required for all entities but only in certain situations
Y-NA-NM
REF
periods reporting date (the balance sheet that includes comparative information under previous GAAP) and the balance sheet at the start of the rst IFRS reporting period (the rst period that includes information that complies with IAS 32, IAS 39 and IFRS 4) as arising from a change in accounting policy and should give the disclosures required by IAS 8 para 28(a)-(f) and (i). IAS 8 para 28(f)(i) applies only to amounts presented in the balance sheet at the comparative periods reporting date.
Section B Disclosures required for all entities but only in certain situations
74
PricewaterhouseCoopers
PricewaterhouseCoopers
75
76
PricewaterhouseCoopers
Y-NA-NM
REF
C1 Construction contracts
1p110 11p39(b) 11p39(c) 11p39(a) 11p40 2. 3. 1. Disclose in accounting policies: (a) the methods used to determine the contract revenue recognised in the period; and (b) the methods used to determine the stage of completion of contracts in progress. Disclose the amount of contract revenue recognised as revenue in the period. For construction contracts in progress at the balance sheet date, disclose: (a) the aggregate amount of costs incurred and recognised prots (less recognised losses) to date; (b) the amount of advances received; and (c) the amount of retentions. Present on the balance sheet: (a) the gross amount due from customers for contract work as an asset; and (b) the gross amount due to customers for contract work as a liability.
11p42
4.
C2 Agriculture
1. General disclosures
17p32, 57 The disclosure requirements of IAS 41 apply to owned biological assets and to the amounts of leased biological assets held under nance leases in the lessees accounts. 1. 2. Provide a description of each group of biological assets (narrative or quantied description). Disclose the aggregate gain or loss arising during the current period on initial recognition of biological assets and agricultural produce and from the change in fair value less estimated point-of-sale costs of biological assets. Describe, if it has not been disclosed elsewhere in information published with the nancial statements: (a) the nature of activities involving each group of biological assets; and (b) non-nancial measures or estimates of the physical quantities of: (i) each group of the entitys biological assets at the end of the period; and (ii) the output of agricultural produce during the period. Disclose the methods and signicant assumptions applied in determining the fair value of each group of agricultural produce at the point of harvest and each group of biological assets. Disclose the fair value less estimated point-of-sale costs of agricultural produce harvested during the period, determined at the point of harvest. Disclose: (a) the existence and carrying amounts of biological assets whose title is restricted, and the carrying amounts of biological assets
41p41, 42 41p40
41p46
3.
41p47
4.
41p48
5.
41p49
6.
PricewaterhouseCoopers
77
Y-NA-NM
REF
pledged as security for liabilities; (b) the amount of commitments for the development or acquisition of biological assets; and (c) nancial risk management strategies related to agricultural activity. 41p50 7. Present a reconciliation of changes in the carrying amount of biological assets between the beginning and the end of the current period. Comparative information is not required. The reconciliation should include: (a) the gain or loss arising from changes in fair value less estimated point-of-sale costs. Entities are encouraged to disclose by group or otherwise the amount due to physical changes and due to price changes; (b) increases due to purchases; (c) decreases due to sales and biological assets classied as held for sale (or included in a disposal group that is classied as held for sale) in accordance with IFRS 5; (d) decreases due to harvest; (e) increases resulting from business combinations; (f) net exchange differences arising on the translation of nancial statements into a different presentation currency and on the translation of a foreign operation into the reporting entitys presentation currency; and (g) other changes. This reconciliation should separately identify any biological assets measured at cost loss accumulated depreciation and any accumulated impairment losses in accordance with IAS 41para 30. 8. Disclose the following related to agricultural activity: (a) the nature and extent of government grants recognised in the nancial statements; (b) unfullled conditions and other contingencies relating to government grants; and (c) signicant decreases expected in the level of government grants. Provide a quantied description of each group of biological assets, distinguishing between consumable and bearer biological assets or between mature and immature biological assets, as appropriate.
DV41p51
41p55
41p57
DV41p43
9.
41p55
2.
78
PricewaterhouseCoopers
Y-NA-NM
REF
net prot or loss related to those biological assets: (a) impairment losses; (b) reversals of impairment losses; and (c) depreciation. 41p56 3. If an entity changes from cost to fair value during the current period, disclose: (a) a description of the biological assets; (b) an explanation of why fair value has become reliably measurable; and (c) the effect of the change.
C4 Accounting by a lessor
Leases are nancial instruments; the disclosure requirements of IFRS 7 apply also to leases. Refer to Section A8.
PricewaterhouseCoopers
79
Y-NA-NM
REF
(e) the accumulated allowance for uncollectable minimum lease payments receivable; (f) contingent rents recognised in income; and (g) a general description of the lessors signicant leasing arrangements. 17p65 2. The disclosure requirements set out in para 1 above also apply to sale and leaseback transactions. Any unique or unusual provisions of the agreements or terms of the sale and leaseback transactions should be separately disclosed. The disclosure requirements set out in para 1 above also apply to leases under IFRIC 4.
IFRIC4pBC39 3.
17p65
2.
IFRIC4pBC39 3.
80
PricewaterhouseCoopers
Y-NA-NM
REF
IFRIC5p4
This interpretation applies to accounting in the financial statements of a contributor for interests arising from decommissioning funds that have both of the following features: (a) the assets are administered separately (either by being held in a separate legal entity or as segregated assets within another entity); and (b) a contributor s right to access the assets is restricted. A residual interest in a fund that extends beyond a right to reimbursement, such as a contractual right to distributions once all the decommissioning has been completed or on winding up the fund, may be an equity instrument within the scope of IAS 39 and is not within the scope of this interpretation.
IFRIC5p11 IFRIC5p12
1. 2.
A contributor should disclose the nature of its interest in a fund and any restrictions on access to the assets in the fund. When a contributor has an obligation to make potential additional contributions that is not recognised as a liability (refer to IFRIC 5 para 10), it should make the disclosures required by IAS 37 para 86 (refer to Section A5.23.) When a contributor accounts for its interest in the fund in accordance with IFRIC 5 para 9, it should make the disclosures required by IAS 37 para 85(c) (refer to Section A5.16).
IFRIC5p13
3.
PricewaterhouseCoopers
81
82
PricewaterhouseCoopers
83
PricewaterhouseCoopers
84
PricewaterhouseCoopers
Y-NA-NM
REF
D1 Segment reporting
1. General disclosures
14p3 14p4 The segment information in IAS 14 must be given in the IFRS financial statements of entities whose equity or debt securities are publicly traded or that are in the process of issuing equity or debt securities in public securities markets. Other entities that prepare IFRS financial statements are encouraged to give segment disclosures; if they choose to give such information, they must comply fully with IAS 14. For the detailed rules on determining the segments to be reported in the financial statements, refer to IAS 14 paras 9, 16, 26, 27, 34-37, 41-43, 44 and 47. Refer also to IAS 14, Appendix B, which contains an illustration of the disclosures required for primary and secondary segment reporting formats. 14p81 14p81 14p81 1. 2. Disclose the types of product and service included in each reported business segment. Disclose the composition of each reported geographical segment. If the information required by IAS 14 para 81 is disclosed elsewhere in the annual report, for example in the financial review, it need not be repeated in the financial statements.
14p5
14p52 14p52(A)
14p58 14p61
14p63
DV14p59
PricewaterhouseCoopers
85
Y-NA-NM
REF
reportable segment for the period (for example, the items listed in IAS 1 para 87). 14p64 3. Disclose the aggregate of the entitys share of the net prot or loss of associates, joint ventures (where the equity method is used for joint ventures), or other investments accounted for under the equity method for each reportable segment. However, this requirement only applies if substantially all of those associates operations are within a single segment. If the requirement in para 3 above applies, the aggregate investments in those associates, joint ventures or other investments should also be disclosed for each reportable segment. For each reportable primary segment, disclose: (a) the amount of impairment losses recognised: (i) in the income statement; and (ii) directly in equity; (b) the amount of reversals of impairment losses recognised: (i) in the income statement; and (ii) directly in equity. Where the impairment loss recognised or reversed is material to the nancial statements taken as a whole, the following additional disclosures are required: (a) for an individual asset the segment to which the asset belongs, based on the primary format; and (b) for a cash-generating unit (CGU) description of the CGU (for example, whether it is a business operation, geographical area or reportable segment under IAS 14) and the impairment loss recognised or reversed, by reportable segment based on the primary format. A reconciliation between the information disclosed for reportable segments and the aggregate information in the consolidated or entity nancial statements. As a minimum, the following specic reconciliation requirements apply: (a) segment revenue reconciled to the entitys revenue from external customers, including disclosure of other revenue (revenue from external customers not included in any segments revenue); (b) segment result reconciled to a comparable measure of the entitys operating prot or loss from continuing operations, as well as to the entitys net prot or loss from continuing operations; (c) segment assets reconciled to the entitys assets; (d) segment liabilities reconciled to the entitys liabilities; and (e) segment result from discontinued operations reconciled to prot or loss from discontinued operations. Additional disclosures required, if geographical segments are primary segment format (either (a) or (b) should be applied): (a) if the primary segment format is geographical segments by location of assets, and the location of customers differs from the location of assets, disclose the revenue from sales to external customers for each customer-based geographical segment (sales by destination) whose revenue from sales to external customers is 10% or more of total sales; and (b) if the primary segment format is geographical segments by location of customers, and the assets are located in different
14p66
4.
36p129
5.
36p130
6.
36p130(c) 36p130(d)
14p67
7.
14p71
8.
14p72
86
PricewaterhouseCoopers
Y-NA-NM
REF
geographical areas from the customers, disclose the following segment information for each asset-based geographical segment whose revenue from sales to external customers or segment assets are 10% or more of the group totals: (i) total of segment assets by geographical location of the assets; and (ii) capital expenditure on property, plant and equipment and on intangible assets by location of the assets (determined on an accruals basis, not a cash basis. This disclosure includes both additions and acquisitions through business combinations including goodwill.).
14p70
2.
3.
4. Other disclosures
14p74 1. A business segment or geographical segment for which information is reported to the board of directors and chief executive ofcer is not a reportable segment under IAS 14 if it earns a majority of its revenue from sales to other segments (often referred to in practice as a vertically integrated segment). However, if that segments revenue from sales to external customers is 10% or more of the entitys total external revenue, disclose that fact and the amounts of that segments revenue from: (a) sales to external customers; and (b) internal sales to other segments.
PricewaterhouseCoopers
87
Y-NA-NM
REF
14p75
2.
For inter-segment transfers, disclose: (a) the basis of pricing; and (b) any changes in the basis of pricing inter-segment transfers. Inter-segment transfers should be measured for segment reporting purposes on the basis that the entity actually used to price those transfers.
14p76
3.
Changes in accounting policies adopted for segment reporting that have a material effect on segment information restate prior period segment information unless it is impracticable to do so, and: (a) describe the nature of the change; (b) describe the reason for the change; (c) describe the fact that comparative information has been restated or that it is impracticable to do so; and (d) describe the nancial effect of the change, if it is reasonably determinable. Changes in identication of the segments restate comparatives under the new basis unless this is impracticable. If restatement is impracticable, disclose the current year segment data under both the old and the new basis of segmentation. Previously reported segments that no longer satisfy the quantitative thresholds are not reported separately. An explanation of the reasons why a previously reported segment is no longer reported may be useful in conrming expectations regarding declining markets and changes in the entitys strategies. When an entity adopts IAS 14 for the rst time, the comparative segment data should be restated unless it is not practicable. If it is not practicable, disclose that fact.
14p76
4.
DV14p83
5.
14p84
6.
33p66
2.
33p67
3.
88
PricewaterhouseCoopers
Y-NA-NM
REF
33p68
4.
An entity that reports a discontinuing operation should disclose the basic and diluted amounts per share for the discontinuing operation either on the face of the income statement or in the notes to the nancial statements. Present basic and diluted earnings per share, even if the amounts are negative (a loss per share). Disclose: (a) the amounts used as the numerators in calculating basic and diluted earnings per share, and a reconciliation of those amounts to prot or loss attributable to the parent entity for the period. The reconciliation should include the individual effect of each class of instruments that affects earnings per share; (b) the weighted average number of ordinary shares used as the denominator in calculating basic and diluted earnings per share, and a reconciliation of these denominators to each other. The reconciliation should include the individual effect of each class of instruments that affects earnings per share; and (c) instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future, but were not included in the calculation of diluted earnings per share because they are antidilutive for the period(s) presented. Provide a description of ordinary share transactions or potential ordinary share transactions, other than those accounted for in accordance with IAS 33 para 64, that occur after the balance sheet date and that would have changed signicantly the number of ordinary shares or potential ordinary shares outstanding at the end of the period if those transactions had occurred before the end of the reporting period. Examples are provided in IAS 33 para 71.
33p69
5. 6.
33p70(a)
33p70(b)
33p70(c)
33p70(d)
7.
33p72
8.
Financial instruments generating potential ordinary shares may incorporate terms and conditions that affect the measurement of basic and diluted earnings per share. These terms and conditions may determine whether any potential ordinary shares are dilutive and, if so, the effect on the weighted average number of shares outstanding and any consequent adjustments to prot or loss attributable to equity holders. The disclosure of the terms and conditions of such nancial instruments and other contracts is encouraged, if not otherwise required (refer to IFRS 7). If an entity discloses, in addition to basic and diluted earnings per share, amounts per share using a reported component of the income statement other than one required by IAS 33, such amounts should be calculated using the weighted average number of ordinary shares determined in accordance with this standard. Basic and diluted amounts per share relating to such a component should be disclosed with equal prominence and presented in the notes to the nancial statements. An entity should indicate the basis on which the numerator(s) is (are) determined, including whether amounts per share are before tax or after tax. If a component of the income statement is used that is not reported as a line item in the income statement, a reconciliation should be provided between the component used and the line item that is reported in the income statement.
33p73
9.
PricewaterhouseCoopers
89
90
PricewaterhouseCoopers
Section E Additional disclosures required for entities that issue insurance contracts
92
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS4p36
IFRS4p37
IFRS4p38
2.
IFRS4p39
PricewaterhouseCoopers
93
Section E
Y-NA-NM
REF
(d) information about credit risk, liquidity risk and market risk that paragraphs 31-42 of IFRS 7 would require if the insurance contracts were within the scope of IFRS 7. However: (i) an insurer need not provide the maturity analysis required by paragraph 39(a) of IFRS 7 if it discloses information about the estimated timing of the net cash outows resulting from recognised insurance liabilities instead. This may take the form of an analysis, by estimated timing, of the amounts recognised in the balance sheet. (ii) if an insurer uses an alternative method to manage sensitivity to market conditions, such as an embedded value analysis, it may use that sensitivity analysis to meet the requirement in paragraph 40(a) of IFRS 7. Such an insurer shall also provide the disclosures required by paragraph 41 of IFRS 7. (e) information about exposures to market risk arising from embedded derivatives contained in a host insurance contract if the insurer is not required to, and does not, measure the embedded derivatives at fair value. IFRS7p30 3. Some nancial assets and nancial liabilities contain a discretionary participation feature as described in IFRS 4. If an entity cannot measure reliably the fair value of that feature, disclose that fact together with a description of the contract, its carrying amount, an explanation of why fair value cannot be measured reliably, information about the market for the instrument, information about whether and how the entity intends to dispose of the instrument and, if nancial instruments whose fair value previously could not be reliably measured are derecognised, that fact, their carrying amount at the time of derecognition, and the amount of gain or loss recognised. The issuer need not disclose the amount that would result from applying IAS 39 to the guaranteed element of a participation feature, nor does it need to present that amount separately. The issuer need not determine that amount if the total liability recognised is clearly higher. To comply with paragraph 39(c)(i), an insurer shall disclose either (a) or (b) as follows: (a) a sensitivity analysis that shows how prot or loss and equity would have been affected had changes in the relevant risk variable that were reasonably possible at the balance sheet date occurred; the methods and assumptions used in preparing the sensitivity analysis; and any changes from the previous period in the methods and assumptions used. However, if an insurer uses an alternative method to manage sensitivity to market conditions, such as an embedded value analysis, it may meet this requirement by disclosing that alternative sensitivity analysis and the disclosures required by paragraph 41 of IFRS 7. (b) qualitative information about sensitivity, and information about those terms and conditions of insurance contracts that have a material effect on the amount, timing and uncertainty of the insurers future cash ows.
IFRS4p35(b) 4.
IFRS4p39A
5.
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS4p42
6.
An entity need not apply the disclosure requirements in IFRS 4 to comparative information that relates to annual periods beginning before 1 January 2005, except for the disclosures required by IFRS 4 para 37(a) and (b) about accounting policies, and recognised assets, liabilities, income and expense (and cash ows if the direct method is used). If it is impracticable to apply a particular requirement of IFRS 4 paras 10-35 to comparative information that relates to annual periods beginning before 1 January 2005, disclose that fact. Applying the liability adequacy test (IFRS 4 paras 15-19) to such comparative information may be impracticable, but it is unlikely to be impracticable to apply other requirements of IFRS 4 paras 10-35 to such comparative information. IAS 8 explains the term impracticable .
IFRS4p43
7.
IFRS4p44
8.
In applying IFRS 4 para 39(c)(iii) disclosure of actual claims compared with previous estimates an entity need not disclose information about claims development that occurred earlier than ve years before the end of the rst nancial year in which it applies IFRS 4. If it is impracticable, when an entity first applies IFRS 4, to prepare information about claims development that occurred before the beginning of the earliest period for which an entity presents full comparative information that complies with IFRS 4, disclose that fact.
9.
39p103B, IFRS4p41A
Amendments to IAS 39 and IFRS 4 were issued in August 2005. A new denition of nancial guarantee contracts was added in IAS 39 and IFRS 4. The disclosure requirements for nancial guarantees are included in Section A8.11.
PricewaterhouseCoopers
95
96
PricewaterhouseCoopers
PricewaterhouseCoopers
97
98
PricewaterhouseCoopers
Y-NA-NM
REF
F
26p13
26p17, 35(d) 2.
26p35(a)
3.
26p34(a) 26p35(b)
4.
PricewaterhouseCoopers
99
Y-NA-NM
REF
26p32
(vii) description of retirement benets promised to participants; (viii) description of any plan termination terms; and (ix) changes in the above items during the period covered by the report; and (e) for plan investments for which an estimate of fair value is not possible, the reason why fair value is not used. IAS 26 paras 16, 22 and 36 provide guidance on disclosures.
5.
26p19
For dened benet plans, disclose the following: (a) signicant actuarial assumptions made; (b) date of the most recent actuarial valuation; (c) the method used to calculate present value of promised retirement benets; (d) the effect of any changes in actuarial assumptions that have had a signicant effect on the actuarial present value of promised retirement benets; and (e) an explanation of the relationship between the actuarial present value of promised retirement benets and the net assets available for benets.
100
PricewaterhouseCoopers
Section G Suggested disclosures for nancial review outside the nancial statements
PricewaterhouseCoopers
101
102
PricewaterhouseCoopers
Y-NA-NM
REF
G
DV1p9
DV1p10
2.
IFRS does not address the requirements for information to be included in a directors report or nancial commentary. These requirements are generally determined by local laws and regulations. Companies may present, outside the nancial statements, a nancial review by management that describes and explains the main features of the entitys nancial performance and nancial position and the principal uncertainties it faces.
IOSCOs standard on operating and nancing reviews for prospectuses Section G Suggested disclosures for nancial review outside the nancial statements
103
In 1998, IOSCO issued International Disclosure Standards for CrossBorder Offerings and Initial Listings for Foreign Issuers , comprising recommended disclosure standards including an operating and financial review and discussion of future prospects. IOSCO standards for prospectuses are not mandatory, but they will increasingly be incorporated in national stock exchange requirements both for prospectuses and annual reports. The text of IOSCO s standard on Operating and Financial Reviews and Prospects is reproduced below: Discuss the companys nancial condition, changes in nancial condition and results of operations for each year and interim period for which nancial statements are required, including the causes of material changes from year to year in nancial statement line items, to the extent necessary for an understanding of the companys business as a whole. Information provided also should relate to all separate segments of the company. Provide the information specied below as well as such other information that is necessary for an investors understanding of the companys nancial condition, changes in nancial condition and results of operation. 1. Operating Results. Provide information regarding signicant factors, including unusual or infrequent events or new developments, materially affecting the companys income from operations, indicating the extent to which income was so affected. Describe any other signicant component of revenue or expenses necessary to understand the companys results of operations. (a) To the extent that the nancial statements disclose material changes in net sales or revenues, provide a narrative discussion
PricewaterhouseCoopers
Y-NA-NM
REF
of the extent to which such changes are attributable to changes in prices or to changes in the volume or amount of products or services being sold or to the introduction of new products or services. (b) Describe the impact of ination, if material. If the currency in which nancial statements are presented is of a country that has experienced hyperination, the existence of such ination, a ve year history of the annual rate of ination and a discussion of the impact of hyperination on the companys business should be disclosed. (c) Provide information regarding the impact of foreign currency uctuations on the company, if material, and the extent to which foreign currency net investments are hedged by currency borrowings and other hedging instruments. (d) Provide information regarding any governmental economic, scal, monetary or political policies or factors that have materially affected, or could materially affect, directly or indirectly, the companys operations or investments by host country shareholders. 2. Liquidity and Capital Resources. The following information should be provided: (a) Information regarding the companys liquidity (both short and long term), including: (i) a description of the internal and external sources of liquidity and a brief discussion of any material unused sources of liquidity. Include a statement by the company that, in its opinion, the working capital is sufcient for the companys present requirements, or, if not, how it proposes to provide the additional working capital needed; (ii) an evaluation of the sources and amounts of the companys cash ows, including the nature and extent of any legal or economic restrictions on the ability of subsidiaries to transfer funds to the company in the form of cash dividends, loans or advances and the impact such restrictions have had or are expected to have on the ability of the company to meet its cash obligations; and (iii) information on the level of borrowings at the end of the period under review, the seasonality of borrowing requirements and the maturity prole of borrowings and committed borrowing facilities, with a description of any restrictions on their use. (b) Information regarding the type of nancial instruments used, the maturity prole of debt, currency and interest rate structure. The discussion also should include funding and treasury policies and objectives in terms of the manner in which treasury activities are controlled, the currencies in which cash and cash equivalents are held, the extent to which borrowings are at xed rates, and the use of nancial instruments for hedging purposes. (c) Information regarding the companys material commitments for capital expenditures as of the end of the latest nancial year and any subsequent interim period and an indication of the general purpose of such commitments and the anticipated sources of funds needed to full such commitments.
Section G Suggested disclosures for nancial review outside the nancial statements
104
PricewaterhouseCoopers
Y-NA-NM
REF
3.
Research and Development, Patents and Licenses etc. Provide a description of the companys research and development policies for the last three years, where it is signicant, including the amount spent during each of the last three nancial years on company-sponsored research and development activities. Trend Information. The company should identify the most signicant recent trends in production, sales and inventory, the state of the order book and costs and selling prices since the latest nancial year. The company also should discuss, for at least the current nancial year, any known trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on the companys net sales or revenues, income from continuing operations, protability, liquidity or capital resources, or that would cause reported nancial information not necessarily to be indicative of future operating results or nancial condition.
4.
PricewaterhouseCoopers
105
Section G Suggested disclosures for nancial review outside the nancial statements
106
PricewaterhouseCoopers
PricewaterhouseCoopers
107
108
PricewaterhouseCoopers
Y-NA-NM
REF
1. 2. 3.
Identify the nancial statements and distinguish them from other information in the same published documents. Identify each nancial statement and the notes. Include the following components in the nancial statements: (a) a statement of nancial position (balance sheet) at the period end date; (b) a statement of comprehensive income for the period; (c) separate income statement (if presented); (d) a statement of changes in equity for the period; (e) a statement of cash ows for the period; (f) notes, including a summary of signicant accounting policies and other explanatory information. Where an income statement is presented, this should be immediately before the statement of comprehensive income.
Where an entity applies an accounting policy retrospectively or makes a retrospective restatement of items, or reclassies items in its nancial statements, include a statement of nancial position as at the beginning of the earliest comparative period. Make an explicit and unreserved statement in the notes that the nancial statements comply with IFRS. Financial statements should not be described as complying with IFRS unless they comply with all the requirements of IFRS.
1p16
5.
1p20
6.
In extremely rare circumstances where an entity departs from a requirement in IFRS because compliance with that requirement would be so misleading as to conict with the objective of nancial statements set out in the Framework, disclose: (a) that management has concluded that the nancial statements present fairly the nancial position, nancial performance and cash ows of the entity; (b) that it has complied with applicable IFRSs, except that it has departed from a particular requirement in order to achieve a fair presentation; (c) the title of the IFRS from which the entity has departed and the nature of the departure, including the treatment that the IFRS would require, the reason why that treatment would be so misleading, and the treatment adopted; and (d) for each period presented, the nancial effect of the departure on each item in the nancial statements that would have been reported in complying with the requirement. Where an entity has departed from a requirement of an IFRS in a prior period and the amounts recognised in the current period are affected by that departure, make disclosures (c) and (d) above. Where management concludes that compliance with a requirement in IFRS would be so misleading as to conict with the objective of nancial statements set out in the Framework, but departure from the requirement is prohibited by the relevant regulatory framework,
1p21
7.
1p23
8.
PricewaterhouseCoopers
109
Y-NA-NM
REF
reduce the perceived misleading aspects of compliance as far as possible by disclosing: (a) the title of the IFRS in question, the nature of the requirement and the reason why management considers compliance with that requirement to be so misleading as to conict with the objective of nancial statements set out in the Framework; and (b) for each period presented, the adjustments to each item in the nancial statements that management has concluded would be necessary to give a fair presentation. 1p25 9. Make an assessment of the entitys ability to continue as a going concern. Where management is aware of material uncertainties related to events or conditions that may cast signicant doubt on the entitys ability to continue as a going concern, disclose those uncertainties.
1p25
10. Where the nancial statements are not prepared on a going concern basis, disclose that fact, together with the basis on which the nancial statements are prepared and the reason why the entity is not regarded as a going concern. 11. Where an entity has changed the end of its reporting period and prepares nancial statements for a period of less than or more than one year, disclose: (a) the period covered by the nancial statements; (b) the reason for using a longer or shorter period; and (c) the fact that amounts presented in the nancial statements are not entirely comparable. 12. Disclose comparative information in respect of the previous period for all amounts reported in the current periods nancial statements, except where IFRSs permit or require otherwise. This includes comparative information for both narrative and descriptive information where it is relevant to understanding the nancial statements for the current period. 13. Where an entity has reclassied comparative amounts due to a change in presentation or classication of items in its nancial statements, disclose: (a) the nature of the reclassication; (b) the amount of each item or class of item that is reclassied; and (c) the reason for the reclassication. When an entity changes the presentation or classication of items in its nancial statements, reclassify comparative amounts unless it is impracticable to do so.
1p36
1p38
1p41
1p42
14. Where an entity changes the presentation or classication of items, but it is impracticable to reclassify comparative amounts, disclose: (a) the reason for not reclassifying the amounts; and (b) the nature of the adjustments that would have been made if the amounts had been reclassied. 15. Display the following information prominently, and repeat where necessary for the information presented to be understood: (a) the name of the reporting entity or other means of identication, and any change in that information from the end of the previous reporting period;
1p51
110
PricewaterhouseCoopers
Y-NA-NM
REF
(b) whether the nancial statements are for an individual entity or a group; (c) the date of the end of the reporting period or the period covered by the nancial statements and notes; (d) the presentation currency (dened in IAS 21); (e) the level of rounding used in presenting amounts in the nancial statements.
1p82
2.
1p83
3.
1p84 1p85 4.
1p87
5.
No item of income or expense is shown as an extraordinary item, either in the statement of comprehensive income (or the separate income statement, if presented), or in the notes.
PricewaterhouseCoopers
111
Present additional line items, headings and sub-totals in the statement of comprehensive income (and the separate income statement, if presented) when such presentation is relevant to an understanding of the entitys nancial performance.
Y-NA-NM
REF
1p90
6.
Disclose, either in the statement of comprehensive income or in the notes, the amount of income tax relating to each component of other comprehensive income including reclassication adjustments. Disclose reclassication adjustments relating to components of other comprehensive income. Disclose separately the nature and amount of items of income or expense that are material. Give an analysis of expenses recognised in prot or loss using a classication based on either their nature or their function within the entity, whichever provides information that is reliable and more relevant.
7. 8. 9.
1p104
10. Where the entity classies expenses by function, disclose additional information on the nature of expenses, including depreciation, amortisation and employee benets expense.
1p107
2.
1.
The statement of nancial position, as a minimum, includes the following line items: (a) property, plant and equipment; (b) investment property; (c) intangible assets; (d) nancial assets (excluding amounts shown under (e), (h) and (i)); (e) investments accounted for using the equity method; (f) biological assets; (g) inventories; (h) trade and other receivables; (i) cash and cash equivalents; (j) the total of assets classied as held for sale and assets included in disposal groups classied as held for sale in accordance with IFRS 5; (k) trade and other payables; (l) provisions; (m) nancial liabilities (excluding amounts shown under (k) and (l)); (n) liabilities and assets for current tax, as dened in IAS 12;
112
PricewaterhouseCoopers
Y-NA-NM
REF
(o) deferred tax liabilities and deferred tax assets, as dened in IAS 12; (p) liabilities included in disposal groups classied as held for sale in accordance with IFRS 5; (q) minority interest, presented within equity; and (r) issued capital and reserves attributable to owners of the parent. 1p55 Present additional line items, heading and subtotals on the face of the statement of nancial position when such presentation is relevant to an understanding of the entitys nancial position. 2. Disclose further sub-classications of the line items presented, classied in a manner appropriate to the entitys operations. This disclosure is made either in the statement of nancial position or in the notes. Is the current/non-current distinction of assets and liabilities made on the face of the balance sheet? (a) Yes ensure that classication rules in IAS 1 paras 66 - 76 are applied; (b) No in this exception, ensure that a presentation based on liquidity provides information that is reliable and more relevant. Ensure also that assets and liabilities are presented in order of their liquidity. An entity is permitted to use a mixed basis of presentation when this provides information that is reliable and more relevant for example, when an entity has diverse operations. 4. Whichever method of presentation in para 3 above is applied, disclose the non-current portion (the amount expected to be recovered or settled after more than 12 months) for each asset and liability item that combines current and non-current amounts. Disclose the following information either in the statement of nancial position or in the notes: (a) for each class of share capital: (i) the number of shares authorised; (ii) the number of shares issued and fully paid, and issued but not fully paid; (iii) the par value per share, or that the shares have no par value; (iv) a reconciliation between the number of shares outstanding at the beginning and the end of the reporting period; (v) the rights, preferences and restrictions for each class of share, including restrictions on dividends and the repayment of capital; (vi) shares in the entity held by the entity itself of by its subsidiaries or associates; and (vii) shares reserved for issue under options and contracts for the sale of shares, including the terms and amounts; and (b) a description of the nature and purpose of each reserve within equity. If the entity has no share capital, disclose information equivalent to that under para 5 above, showing changes in each category of equity interest during the period, and the rights, preferences and restrictions attaching to each category of equity interest.
1p77
1p60
3.
1p64
1p61
1p79
5.
1p80
6.
PricewaterhouseCoopers
113
Y-NA-NM
REF
1p113
2.
1p117
3.
1p122
4.
1p125
5.
1p134, 135
6.
114
PricewaterhouseCoopers
Y-NA-NM
REF
1p137
7.
Disclose in relation to dividends: (a) the amount of dividends proposed or declared before the nancial statements were authorised for issue but not recognised as a distribution to owners in the period, and the related amount per share; and (b) the amount of any cumulative preference dividends not recognised. Disclose the following: (a) the domicile and legal form of the entity, the country in which it is incorporated and the address of its registered ofce (or principal place of business, if different from the registered ofce); (b) a description of the nature of the entitys operations and its principal activities; and (c) the name of the parent and the ultimate parent of the group.
1p138
8.
PricewaterhouseCoopers
115
116
PricewaterhouseCoopers
PricewaterhouseCoopers
117
118
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS8p20
1.
Disclose information to enable users to evaluate the nature and nancial effects of the business activities in which the entity engages and the economic environment in which it operates. Disclose the following general information: (a) the factors used in identifying the entitys reportable segments, including the basis of organisation (for example, by geographical area, products and services, or a combination of factors); and (b) the types of products and services from which each reportable segment generates revenues. Give reconciliations of balance sheet amounts for reportable segments to the entitys balance sheet amounts for each date at which a balance sheet is presented. Provide reconciliations (and narrative to describe the reconciling items) of the following: (a) the total of reportable segments revenues to the entitys revenue; (b) the total of the reportable segments measure of prot or loss to the entitys prot or loss before tax and discontinued operations, unless items such as tax income and expense are allocated to segments, in which case the reconciliation may be to the entitys prot or loss after those items; (c) the total of the reportable segments assets to those of the entity; (d) the total of the liabilities of the reportable segments to those of the entity (where segment liabilities are reported); and (e) for any other material item from the total for the reportable segments to the corresponding amount for the entity. Where there has been a change in the composition of the entitys reportable segments, disclose whether it has restated the corresponding items of segment information for earlier periods. Where there is such a change, restate corresponding information unless the information is not available and the cost to develop would be excessive. Make this decision for each individual item of disclosure.
IFRS8p22
2.
IFRS8p21
3.
IFRS8p28
4.
IFRS8p29
5.
IFRS8p30
6.
Where there has been a change in the composition of the entitys reportable segments and segment information for prior periods is not restated, restate in the year in which the change occurs, segment information for the current year on both the old basis and the new basis of segmentation (unless the necessary information is not available and the cost to develop it would be excessive).
IFRS8p23
2.
PricewaterhouseCoopers
119
Section I
Y-NA-NM
REF
(a) revenues from external customers; (b) revenues from transactions with other operating segments of the same entity; (c) interest revenue; (d) interest expense; (e) depreciation and amortisation; (f) material items of income and expense disclosed in accordance with IAS 1.86; (g) the entitys interest in the prot or loss of associates and joint ventures accounted for by the equity method; (h) income tax income or expense; and (i) material non-cash items (other than depreciation and amortisation). Disclose interest revenue net of interest expense only when the majority of the segments revenues are from interest and the chief operating decision-maker relies primarily on net interest revenue in assessing the performance of the segment. Disclose when this has been done. IFRS8p24 3. Disclose the following about segment assets for each reportable segment if the information is included in the measure of segment assets reviewed by the chief operating decision-maker or is otherwise regularly provided to the chief operating decision maker: (a) the amount of investments in associates and joint ventures accounted for using the equity method; and (b) the amount of additions to non-current assets other than nancial instruments, deferred tax assets, post-employment benet assets and rights arising under insurance contracts. Provide an explanation of the measurements of prot or loss, assets and liabilities for each reportable segment, including: (a) the basis of accounting for any transactions between reportable segments; (b) the nature of any differences between the measurements of prots or losses of the reportable segments and those of the entity before income tax and discontinued operations; (c) the nature of any differences between the measurement of the assets of the reportable segments and those of the entity; (d) the nature of any differences between the measurement of the liabilities of the reportable segments and those of the entity; (e) the nature and effect of any changes from previous periods in the measurement methods used to determined reported segment prot or loss; and (f) the nature and effect of any asymmetrical allocations to reportable segments (for example, where depreciation expense is allocated to a segment but the related asset is not).
IFRS8p27
4.
3. Entity-wide disclosures
IFRS8p31 Provide the following information if it is not provided as part of the reportable segment information. Disclose it, based on the nancial information used to produce the entitys nancial statements: 1. The revenues from external customers for each group of similar products and services, unless the information is not available and the cost to develop it would be excessive, in which case, disclose that fact. The amounts of the revenues are based on the revenue per the nancial statements.
IFRS8p32
120
PricewaterhouseCoopers
Y-NA-NM
REF
IFRS8p33
2.
The following geographical information, unless the necessary information is not available and the cost to develop it would be excessive (if this is the case, disclose this fact): (a) revenues for external customers split between those attributable to the entitys country of domicile and all foreign countries in total from which the entity derives revenues. Disclose the basis for attributing revenues to individual countries, and the revenue attributed to an individual foreign country if that revenue is material; and (b) non-current assets (other than nancial instruments, deferred tax assets, post-employment benet assets and rights arising under insurance contracts) split between those located in the entitys country of domicile and those located in all foreign countries in total in which the entity holds assets. If assets in an individual foreign country are material, disclose those assets separately. The amounts of the assets and revenues are based on the amounts per the nancial statements.
IFRS8p34
3.
Information about the extent of the entitys reliance on its major customers. If revenues from transactions with a single external customer are 10% or more of the entitys revenues, disclose that fact, along with the total amounts of revenues from each such customer and the identity of the segments reporting the revenues.
PricewaterhouseCoopers
121
Section I
122
PricewaterhouseCoopers
PricewaterhouseCoopers
123
124
PricewaterhouseCoopers
Y-NA-NM
REF
34p9, 10
34p9
34p20
2.
Interim reports should include interim nancial statements (condensed or complete) for periods as follows: (a) balance sheet as of the end of the current interim period and a comparative balance sheet as of the end of the immediately preceding nancial year; (b) income statements for the current interim period and cumulatively for the current nancial year to date, with comparative income statements for the comparable interim periods (current and yearto-date) of the immediately preceding nancial year; (c) statement showing changes in equity cumulatively for the current nancial year to date, with a comparative statement for the comparable year-to-date period of the immediately preceding nancial year; and (d) cash ow statement cumulatively for the current nancial year to date, with a comparative statement for the comparable year-todate period of the immediately preceding nancial year. An interim nancial report should include, at a minimum, the following components: (a) condensed balance sheet; (b) condensed income statement; (c) condensed statement showing either: (i) all changes in equity; or (ii) changes in equity except those arising from capital transactions with owners and distributions to owners (ie, statement of income and expense recognised in equity); (d) condensed cash ow statement; and (e) selected explanatory notes (refer to para 6 below). Condensed primary statements should include, at a minimum, each of the headings and subtotals that were included in the most recent annual nancial statements. Additional line items and notes should be included if their omission would make the condensed interim nancial statements misleading.
34p8
3.
34p10
4.
PricewaterhouseCoopers
125
Y-NA-NM
REF
34p11 34p16
5. 6.
Basic and diluted earnings per share should be presented on the face of an interim income statement, if applicable. Disclose, as a minimum, the following information in the notes, if material and if it is not disclosed elsewhere in the interim nancial report: (a) a statement that the same accounting policies are followed in the interim nancial statements as compared with the most recent annual nancial statements; or, if those policies have been changed, a description of the nature and effect of the change; (b) explanatory comments about the seasonality or cyclicality of interim operations; (c) the nature and amount of items affecting assets, liabilities, equity, net income, or cash ows that are unusual because of their nature, size, or incidence (refer to examples in IAS 34 para 17); (d) the nature and amount of changes in estimates of amounts reported in prior interim periods of the current year, or in prior years, if those changes have a material effect in the current interim period (for example, changes in estimates relating to inventory write-downs and impairment losses); (e) issuances, repurchases, and repayments of debt and equity securities; (f) dividends paid (aggregate or per share), separately for ordinary shares and other shares; (g) segment revenue and segment result for segments in primary segment format (only if IAS 14 is applicable for this entity refer to Section D1); (h) material events subsequent to the end of the interim period that have not been reected in the nancial statements for the interim period; (i) the effect of changes in the composition of the entity during the interim period (for example, business combinations, disposals, restructurings and discontinued operations). In the case of business combinations, the entity should disclose the information required to be disclosed under IFRS 3 paras 66-73; and (j) changes in contingent liabilities and assets since the last annual balance sheet date. Examples of the types of disclosure that are required by IAS 34 para 16 are set under IAS 34 para 17.
In addition to the items in para 6 above, the entity should also disclose any other events or transactions that are material to an understanding of the current interim period.
PricewaterhouseCoopers
Y-NA-NM
REF
34p19
8.
Disclose that the interim nancial statements comply with IAS 34. An interim financial report should not be described as complying with IFRS unless it complies with all of the requirements of each applicable standard and each applicable interpretation of the International Financial Reporting Interpretations Committee.
DV34p21
9.
For an entity whose business is highly seasonal, financial information for the 12 months ending on the interim reporting date and comparative information for the prior 12-month period may be useful.
For a first-time adopter preparing its first IFRS financial statements, the entity should satisfy the IAS 34 requirements and the requirements set out in B8.5.
IFRS Disclosure Checklist 2007 is designed for the information of readers. While every effort has been made to ensure accuracy, information contained in this publication may not be comprehensive or may have been omitted that may be relevant to a particular reader. In particular, this checklist is not intended as a study of all aspects of IFRS, or as a substitute for reading the standards and interpretations when dealing with specic issues. No responsibility for loss to any person acting or refraining from acting as a result of any material in this checklist can be accepted by PricewaterhouseCoopers. Recipients should not act on the basis of this checklist without seeking professional advice.
PricewaterhouseCoopers
127
Notes
128
PricewaterhouseCoopers
IFRS for SMEs Is it relevant for your business? It outlines why some unlisted SMEs have already made the change to IFRS and illustrates what might be involved in a conversion process.
Making the change to IFRS This 12-page brochure provides a high-level overview of the key issues that companies need to consider in making the change to IFRS.
To order copies of any of these publications, contact your local PricewaterhouseCoopers ofce or visit www.cch.co.uk/ifrsbooks
IFRS tools
COMPERIO
Your Path to Knowledge
Comperio
Your path to knowledge Online library of nancial reporting and assurance literature. Provides the full text of IASB literature as well as ISAs, International Auditing Practice Statements and IPSAS. Also contains PwCs IFRS and corporate governance publications, and Applying IFRS. For more information, visit www.pwc.com/comperio
About PricewaterhouseCoopers PricewaterhouseCoopers (www.pwc.com) is the worlds largest professional services organisation. Drawing on the knowledge and skills of 125,000 people in 142 countries, we build relationships by providing services based on quality and integrity. Contacting PricewaterhouseCoopers Please contact your local PricewaterhouseCoopers ofce to discuss how we can help you make the change to International Financial Reporting Standards or with technical queries. See inside back cover for further details of IFRS products and services.
2007 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member rms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
UP/GCR063BI7001